	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S18-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
S103-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
S77-PMC2290997	PMC2290997	4/2008	S77-PMC2290997	['a swedish epidemiologic study published in the december 2006 issue of diabetologia FOUND that sufficient Vitamin D status in early Life was ASSOCIATED with a lower risk of developing type 1 diabetes.']	[('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0000104', 'life cycle', 131, 'life')]
S79-PMC2290997	PMC2290997	4/2008	S79-PMC2290997	['and a finnish study published 3 november 2001 in the lancet SHOWED that children who received 2,000 iu Vitamin D per day from 1 year of age on had an 80% decreased risk of developing type 1 diabetes later in Life, WHEREAS children who were Vitamin D deficient had a fourfold increased risk.']	[('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000104', 'life cycle', 208, 'life'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
S111-PMC2290997	PMC2290997	4/2008	S111-PMC2290997	['in the context of INADEQUATE sunlight or Vitamin D insufficiency, SOME scientists WORRY that the EMPHASIS on preventing skin cancers tends to obscure the much larger mortality BURDEN posed by more Life-threatening cancers such as Lung, Colon, and Breast cancers.']	[('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 66), ('IMPORTANT_CONSIDERATION', 82), ('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 176)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0000104', 'life cycle', 197, 'life'), ('UBERON_0002048', 'lung', 230, 'lung'), ('UBERON_0001155', 'colon', 236, 'colon'), ('UBERON_0000310', 'breast', 247, 'breast')]
S12-PMC2685863	PMC2685863	5/2009	S12-PMC2685863	['the researchers REASON that a lack of Vitamin D in the Thymus in early Life COULD limit this process, THUS enabling “self-directed” T Cells to survive and trigger an Autoimmune response to the Myelin Sheath on Nerve Fibers—a classic feature of ms.']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 102)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0002370', 'thymus', 55, 'thymus'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('CL_0000084', 'T cell', 132, 'T cells'), ('UBERON_0001442', 'skeleton of manus', 166, 'autoimmune'), ('UBERON_0000347', 'entire myelin sheath', 193, 'myelin sheath'), ('UBERON_0006134', 'nerve fiber', 210, 'nerve fibers')]
S124-PMC2872349	PMC2872349	4/2010	S124-PMC2872349	['in summary Maternal behavior, in the form of activities such as smoking, dietary choices including Calcium and Vitamin D intake, and alterations in the Endocrine pathways especially in early Life, HAVE BEEN SHOWN to CORRELATE with offspring bone health [48,50,54,55].']	[('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 216)]	2	[('GO_0007618', 'mating', 11, 'maternal'), ('CHEBI_22313', 'alkaline earth metal atom', 99, 'calcium'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0006397', 'mRNA processing', 152, 'endocrine'), ('UBERON_0000104', 'life cycle', 191, 'life')]
S137-PMC2889879	PMC2889879	5/2010	S137-PMC2889879	['results from the northern finland 1966 Birth cohort SHOWED that Vitamin D supplementation during the first year of Life was ASSOCIATED with a reduced risk of schizophrenia in males, BUT NOT in women [32].']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 124), ('FULL_UNKNOWN', 182)]	3	[('GO_0007567', 'parturition', 39, 'Birth'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000104', 'life cycle', 115, 'life')]
S142-PMC2889879	PMC2889879	5/2010	S142-PMC2889879	['the absorption of dietary Vitamin D is GENERALLY high at all stages of Life [34], BUT Serum levels also depend on the endogenous Production Of Vitamin D due to sun exposure which is subject to seasonal VARIATIONS.']	[('PROBABLE_UNDERSTANDING', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('DIFFICULT_TASK', 202)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 129, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
S109-PMC2963768	PMC2963768	10/2010	S109-PMC2963768	['THEREFORE, the MAJOR REASON that bangladeshi infants start Life with POOR Vitamin D stores is low maternal Antenatal 25(Oh)D, which HAS BEEN DOCUMENTED in urban and rural bangladeshi women of Reproductive age (27).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 141)]	6	[('UBERON_0000104', 'life cycle', 59, 'life'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007567', 'parturition', 107, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 117, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 123, 'D'), ('GO_0000003', 'reproduction', 192, 'reproductive')]
S30-PMC3034879	PMC3034879	12/2010	S30-PMC3034879	['the first was to follow WHETHER the Vitamin D-ASSOCIATED Skeletal EFFECTS observed at Birth persist during the first year of Life, and the second was TO EVALUATE the IMPACT of Postnatal Vitamin D status on bone growth and development in early infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 166)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0004288', 'skeleton', 57, 'skeletal'), ('GO_0007567', 'parturition', 86, 'birth'), ('UBERON_0000104', 'life cycle', 125, 'life'), ('GO_0007567', 'parturition', 176, 'postnatal'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
S192-PMC3034879	PMC3034879	12/2010	S192-PMC3034879	['optimally, Vitamin D sufficiency SHOULD BE guaranteed during fetal Life AS the FINDINGS of the PRESENT STUDY SUGGEST that the CONSEQUENCES of POOR Vitamin D status during the fetal period cannot be totally reverted by Postnatal Vitamin D supplementation.']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 126), ('IMPORTANT_CONSIDERATION', 142)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 218, 'postnatal'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
S2-PMC3061267	PMC3061267	2/2011	S2-PMC3061267	['adequate Vitamin D and Calcium nutrition throughout Life MAY reduce the RISK of osteoporosis, and Calcium supplementation during Pregnancy MAY reduce Preeclampsia and low Birth weight.']	[('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 139)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 23, 'calcium'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('CHEBI_22313', 'alkaline earth metal atom', 98, 'calcium'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 150, 'preeclampsia'), ('GO_0007567', 'parturition', 171, 'birth')]
S33-PMC3061267	PMC3061267	2/2011	S33-PMC3061267	['adequate Vitamin D and calcium nutrition throughout the Life-course APPEAR to reduce the RISK of osteoporosis [10].']	[('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 89)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0000104', 'life cycle', 56, 'life')]
S11-PMC3075531	PMC3075531	7/2010	S11-PMC3075531	['SHOWED that sun exposure in Childhood period PREVENTS from ms.16third, it SEEMS low risk of ms in white population is ASSOCIATED with high Serum level of vitamin d or high oral Intake via supplements or oily fish in SOME STUDIES.217–19fourth, it HAVE BEEN SHOWN that Vitamin D CAN be a PROTECTIVE agent against experimental Autoimmune encephalitis in Mice (like ms in Humans).48finally, some scientists administered 100-1700 iu/day Vitamin D supplements in ms patients and OBSERVED the reduction of relapses.20–22the CANDIDATE for estimating Serum level of Vitamin D is 25-Hydroxy Vitamin D, BECAUSE of its prolonged half-Life.823–25it is used to assess an Individual’s overall Vitamin D nutritional status, BECAUSE its formation, UNLIKE that of 1, 25-Dihydroxy Vitamin D, is not tightly Regulated and it has a relatively long half-life (20-60 days).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 277), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 473), ('INCOMPLETE_EVIDENCE', 517), ('PROBABLE_UNDERSTANDING', 592), ('PROBABLE_UNDERSTANDING', 708), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 731)]	13	[('UBERON_0013628', 'pollical pad', 28, 'childhood'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 324, 'autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 351, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 368, 'humans'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D'), ('UBERON_0001977', 'blood serum', 542, 'serum'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 570, '25-hydroxy vitamin D'), ('UBERON_0000104', 'life cycle', 622, 'life'), ('NCBITaxon_1', 'root', 657, 'individual'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_43176', 'hydroxy group', 752, 'dihydroxy'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0065007', 'biological regulation', 788, 'regulated')]
S55-PMC3075531	PMC3075531	7/2010	S55-PMC3075531	['in a pooled analysis of data from canada, uk, denmark, and sweden including more than 40,000 Individuals with ms, significantly fewer (8.5%) People with ms were Born in november and significantly more (9.1%) were Born in may.39THIS FINDING SUGGESTS that Prenatal exposures or exposures in the first months of Life COULD BE IMPORTANT in ms etiology, BUT the LINK to Vitamin D is UNCLEAR.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 314), ('IMPORTANT_CONSIDERATION', 323), ('ANOMALY_CURIOUS_FINDING', 349), ('SUPERFICIAL_RELATIONSHIP', 357), ('FULL_UNKNOWN', 378)]	8	[('NCBITaxon_1', 'root', 93, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'people'), ('GO_0007567', 'parturition', 161, 'born'), ('GO_0007567', 'parturition', 213, 'born'), ('GO_0007565', 'female pregnancy', 254, 'prenatal'), ('UBERON_0000104', 'life cycle', 309, 'life'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
S13-PMC3103150	PMC3103150	3/2011	S13-PMC3103150	['during the first 6-8 wk of Life, the Vitamin D status of infants is determined by the Vitamin D levels at Birth, which depend ON the Vitamin D status of the mother1.']	[('ANOMALY_CURIOUS_FINDING', 126)]	1	[('UBERON_0000104', 'life cycle', 27, 'life'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
S6-PMC3257641	PMC3257641	3/2010	S6-PMC3257641	['in THIS REVIEW, we OUTLINE the RESEARCH EVIDENCE TO DATE RELATING to Vitamin D status and Pregnancy, including a range of POSSIBLE health outcomes from pre-Conception to later Life (figure 1).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 122)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007620', 'copulation', 156, 'conception'), ('UBERON_0000104', 'life cycle', 176, 'life')]
S8-PMC3257641	PMC3257641	3/2010	S8-PMC3257641	['caption (fig): figure 1\n\nmanifestation of reviewed POSSIBLE major outcomes RELATED to Vitamin D status at different Life Stages.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000104', 'life cycle', 116, 'life stages')]
S85-PMC3257641	PMC3257641	3/2010	S85-PMC3257641	['Immunomodulation\nearly Life Immunomodulation is LIKELY to also be AFFECTED by Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 0, 'Immunomodulation'), ('UBERON_0000104', 'life cycle', 23, 'life'), ('GO_0050900', 'leukocyte migration', 28, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
S118-PMC3257641	PMC3257641	3/2010	S118-PMC3257641	['the diabetes autoimmunity study in the young (daisy) cohort has OBSERVED that Maternal Intake of Vitamin D via Food, recorded at Birth, was significantly ASSOCIATED with a decreased risk of Islet autoimmunity in offspring during the first four years of Life [88].']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 154)]	2	[('GO_0007618', 'mating', 78, 'maternal'), ('GO_0007631', 'feeding behavior', 87, 'intake'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_33290', 'food', 111, 'food'), ('GO_0007567', 'parturition', 129, 'birth'), ('CL_0000214', 'synovial cell', 190, 'islet'), ('UBERON_0002533', 'post-anal tail bud', 190, 'islet'), ('UBERON_0000104', 'life cycle', 253, 'life')]
S120-PMC3257641	PMC3257641	3/2010	S120-PMC3257641	['THESE FINDINGS are also CONSISTENT with the FINDING of an inverse ASSOCIATION between Postnatal Vitamin D supplementation in early Life and type 1 diabetes risk [90,91].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 66)]	4	[('GO_0007567', 'parturition', 86, 'postnatal'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0000104', 'life cycle', 131, 'life')]
S133-PMC3257641	PMC3257641	3/2010	S133-PMC3257641	['in a finnish Birth cohort study, regular Vitamin D supplementation (maternal self-report) during the first year of offspring Life was ASSOCIATED with a reduced risk of schizophrenia in males (but not females) (rr = 0.08, 95% ci 0.01–0.95) [106].']	[('SUPERFICIAL_RELATIONSHIP', 134)]	1	[('GO_0007567', 'parturition', 13, 'birth'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0000104', 'life cycle', 125, 'life')]
S134-PMC3257641	PMC3257641	3/2010	S134-PMC3257641	['OBSERVATIONAL studies provide INDIRECT EVIDENCE that low Vitamin D status during early Life MAY increase the RISK of multiple sclerosis [107,108].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0000104', 'life cycle', 87, 'life')]
S162-PMC3257641	PMC3257641	3/2010	S162-PMC3257641	['in this situation, the timing of low Vitamin D’s EFFECT over the Life Course will HAVE TO BE carefully determined, using specific Life Course analytic techniques [125], TO ASSESS WHETHER any low Prenatal Vitamin D status is INDEPENDENTLY ASSOCIATED with health outcomes INDEPENDENTLY of the mother’s Vitamin D status before Pregnancy and the offspring’s Vitamin D status during Postnatal Life.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 224), ('SUPERFICIAL_RELATIONSHIP', 238), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0001281', 'hepatic sinusoid', 65, 'life course'), ('UBERON_0001281', 'hepatic sinusoid', 130, 'life course'), ('GO_0007565', 'female pregnancy', 195, 'prenatal'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0007567', 'parturition', 378, 'postnatal'), ('UBERON_0000104', 'life cycle', 388, 'life')]
S6-PMC3271033	PMC3271033	1/2012	S6-PMC3271033	['daily Vitamin D intake of 400 iu during the first months of Life APPEARS adequate to increase Serum 25(Oh)D and SUPPORT bmc increases DESPITE low initial 25(Oh)D levels in some infants.']	[('ANOMALY_CURIOUS_FINDING', 65), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 134)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0000104', 'life cycle', 60, 'life'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 102, '(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D')]
S11-PMC3271033	PMC3271033	1/2012	S11-PMC3271033	['formula-Fed infants typically consume 300-500 iu/day from their formula and THEREFORE GENERALLY meet the current recommendations without an additional oral supplement of Vitamin D drops ESPECIALLY after the first 6 to 8 weeks of Life.']	[('PROBABLE_UNDERSTANDING', 76), ('PROBABLE_UNDERSTANDING', 86), ('ANOMALY_CURIOUS_FINDING', 186)]	3	[('GO_0007631', 'feeding behavior', 8, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0000104', 'life cycle', 229, 'life')]
S17-PMC3271033	PMC3271033	1/2012	S17-PMC3271033	"['THIS STUDY was CONDUCTED TO EVALUATE early Life bone Mineral content (bmc) and the EFFECTS of three months of Vitamin D supplementation in Breast-Fed hispanic and non-hispanic caucasian (henceforth, ""caucasian"") infants on Vitamin D levels.']"	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('UBERON_0000104', 'life cycle', 43, 'life'), ('CHEBI_46662', 'mineral', 53, 'mineral'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('UBERON_0000310', 'breast', 139, 'breast'), ('GO_0007631', 'feeding behavior', 146, 'fed'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D')]
S127-PMC3271033	PMC3271033	1/2012	S127-PMC3271033	['regardless, Serum calcium in the Cord Blood and in the first days of Life is LIKELY Controlled by a VARIETY of FACTORS, of which Vitamin D is ONLY one FACTOR.']	[('PROBABLE_UNDERSTANDING', 77), ('DIFFICULT_TASK', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('UBERON_0001977', 'blood serum', 12, 'serum'), ('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('GO_0065007', 'biological regulation', 84, 'controlled'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
S131-PMC3271033	PMC3271033	1/2012	S131-PMC3271033	['it HAS BEEN SUGGESTED BUT is NOT PROVEN that early Life calcium absorption is PRIMARILY non-Vitamin D DEPENDENT [2].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 102)]	5	[('UBERON_0000104', 'life cycle', 51, 'life'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
S138-PMC3271033	PMC3271033	1/2012	S138-PMC3271033	['high doses of Vitamin D in early Life) with or without monitoring of 25(Oh)D levels or WHETHER the 400 iu/day dose is adequate.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 87)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000104', 'life cycle', 33, 'life'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 75, 'D')]
S141-PMC3271033	PMC3271033	1/2012	S141-PMC3271033	['we CANNOT RULE OUT the POSSIBILITY that a SMALL NUMBER OF infants WILL be hypocalcemic in the first weeks of Life with this approach, BUT, this APPEARS TO BE UNCOMMON and MAY BE more RELATED to pth function than Vitamin D. further RESEARCH IS NEEDED relative to the etiology of symptomatic hypocalcemia in the first weeks of life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 48), ('FUTURE_PREDICTION', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 183), ('FUTURE_WORK', 231)]	11	[('UBERON_0000104', 'life cycle', 109, 'life'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
S159-PMC3271033	PMC3271033	1/2012	S159-PMC3271033	['OUR FINDINGS SUPPORT current GUIDELINES to begin Vitamin D supplementation of 400 iu/day to all Breast-Fed infants in the first week of Life and to FURTHER ENCOURAGE the provision of adequate Vitamin D to Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 29), ('FUTURE_WORK', 148), ('FUTURE_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'breast'), ('UBERON_0000310', 'breast', 96, 'breast'), ('GO_0007631', 'feeding behavior', 103, 'fed'), ('UBERON_0000104', 'life cycle', 136, 'life'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('GO_0007565', 'female pregnancy', 205, 'pregnant')]
S34-PMC3277098	PMC3277098	12/2011	S34-PMC3277098	['in non-supplemented infants serum 25(Oh)D status TENDS to decrease over the first few months of Life until sun exposure is increased and Vitamin D-containing Foods introduced into the diet.']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_71657', 'versiconol acetate', 34, '25(OH)D'), ('UBERON_0000104', 'life cycle', 96, 'life'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_33290', 'food', 158, 'foods')]
S35-PMC3277098	PMC3277098	12/2011	S35-PMC3277098	['this RAISES the QUESTION of WHETHER Vitamin D status in utero and early Life has EFFECTS on Immune function and development of allergic disease.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life'), ('UBERON_0002405', 'immune system', 92, 'immune')]
S187-PMC3277098	PMC3277098	12/2011	S187-PMC3277098	['[74] reported that supplementation with 50 µg Vitamin D/day (2000 iu) in the first year of Life was ASSOCIATED with a higher RISK of allergic rhinitis (or 1.66; 95% ci 1.1–1.6, p< 0.001) and atopy (or 1.46; 95% ci 1.4–2.0, p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 125)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0000104', 'life cycle', 91, 'life')]
S196-PMC3277098	PMC3277098	12/2011	S196-PMC3277098	['[70] DEMONSTRATED that children given Vitamin D (400 iu) in Water-soluble form during the first year of Life had an almost two-fold increase in asthma (or 2.18; 95% ci 1.45–3.28), Food allergy (or 1.89; 95% ci 1.33–2.65), and sensitization (or 1.88; 95% ci 1.34–2.64) at 4 years of age compared with children having received the same Vitamins in peanut oil (ALTHOUGH there was no difference in the risk of allergic rhinitis or eczema).']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 358)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_15377', 'water', 60, 'water'), ('UBERON_0000104', 'life cycle', 104, 'life'), ('CHEBI_33290', 'food', 180, 'food'), ('CHEBI_33277', 'gamma-tocotrienol', 334, 'vitamins')]
S205-PMC3277098	PMC3277098	12/2011	S205-PMC3277098	['AS this early Life stage is RELEVANT TO programming of future Immune function it is CRUCIAL to understand the EFFECTS of Vitamin D and identify optimal status levels.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('UBERON_0000104', 'life cycle', 14, 'life'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
S61-PMC3319623	PMC3319623	4/2012	S61-PMC3319623	['furthermore, neonatal Vitamin D levels are significantly ASSOCIATED with RISK of schizophrenia later in Life[26].']	[('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 73)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 104, 'life')]
S11-PMC3338544	PMC3338544	4/2012	S11-PMC3338544	['in a RECENT case-control STUDY, those with low levels of Vitamin D at Birth had a two-fold increase in the risk of developing schizophrenia in later Life[3].']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007567', 'parturition', 70, 'birth'), ('UBERON_0000104', 'life cycle', 149, 'life')]
S86-PMC3347028	PMC3347028	3/2012	S86-PMC3347028	['it is INTERESTING that during Pregnancy alone and at no other time during the Lifecycle there is an uncoupling of Vitamin D Metabolism from calcium such that by the end of the first trimester, 1,25(Oh)2D levels are more than double what they are during the nonpregnant state without concurrent changes in Serum calcium concentrations [6].']	[('ANOMALY_CURIOUS_FINDING', 6)]	1	"[('GO_0007565', 'female pregnancy', 30, 'pregnancy'), ('UBERON_0000104', 'life cycle', 78, 'lifecycle'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 114, 'vitamin D metabolism'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 195, '25(OH)2D'), ('UBERON_0001977', 'blood serum', 305, 'serum')]"
S220-PMC3347028	PMC3347028	3/2012	S220-PMC3347028	['unanswered questions and direction of FUTURE RESEARCH endeavors\nthere are many UNANSWERED QUESTIONS about Vitamin D’s “true” ROLE during Pregnancy: at no other time during the Lifecycle is 25(Oh)D so closely LINKED with 1,25(Oh)2D [6].']	[('FUTURE_WORK', 38), ('ANOMALY_CURIOUS_FINDING', 79), ('EXPLICIT_QUESTION', 90), ('SUPERFICIAL_RELATIONSHIP', 125), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	"[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0000104', 'life cycle', 176, 'lifecycle'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 222, '25(OH)2D')]"
S269-PMC3385441	PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
S92-PMC3395583	PMC3395583	7/2012	S92-PMC3395583	['NOTABLY, schizophrenia is also INFLUENCED by the season of Birth and a RECENT STUDY HAS SHOWN that neonatal Vitamin D levels are significantly ASSOCIATED with risk of schizophrenia later in Life [49,50].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 143)]	5	[('GO_0007567', 'parturition', 59, 'birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000104', 'life cycle', 190, 'life')]
S11-PMC3407995	PMC3407995	7/2012	S11-PMC3407995	['RECENT RESEARCH HAS SHOWN that maternal dietary deficiencies of Docosahexaenoic Acid (Dha), Vitamin D, Folic Acid and Iodine are ASSOCIATED with a variety of poor foetal and/or infant health outcomes MOSTLY IMPACTING Brain Development and/or function in infancy and OFTEN throughout Life.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 129), ('PROBABLE_UNDERSTANDING', 200), ('SUPERFICIAL_RELATIONSHIP', 207), ('PROBABLE_UNDERSTANDING', 266)]	6	[('CHEBI_36003', 'decenoic acid', 64, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 86, 'DHA'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_30751', 'formic acid', 103, 'folic acid'), ('CHEBI_24859', 'iodine atom', 118, 'iodine'), ('GO_0007420', 'brain development', 217, 'brain development'), ('UBERON_0000955', 'brain', 217, 'brain'), ('UBERON_0000104', 'life cycle', 283, 'life')]
S99-PMC3407995	PMC3407995	7/2012	S99-PMC3407995	['there is also evidence from observational studies SUGGESTING that adequate Vitamin D during early Life MAY PREVENT development of Immunological Diseases in the offspring later in Life such as type 1 diabetes [55], allergic diseases [53] and Lower Respiratory Tract infections, wheezing and asthma [56].']	[('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000104', 'life cycle', 98, 'life'), ('GO_0007567', 'parturition', 130, 'immunological diseases'), ('UBERON_0003222', 'flexor digitorum superficialis', 130, 'immunological'), ('UBERON_0000104', 'life cycle', 179, 'life'), ('UBERON_0004905', 'articulation', 241, 'lower respiratory tract')]
S100-PMC3407995	PMC3407995	7/2012	S100-PMC3407995	['THEREFORE at its worst, Vitamin D deficiency CAN be Life threatening to the newborn, WHILE lesser deficiency CAN weaken Skull Bones risking Brain injury during Birth and can CONTRIBUTE to a multitude of future health PROBLEMS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 174), ('IMPORTANT_CONSIDERATION', 217)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('UBERON_0003215', 'alveolus', 120, 'skull bones'), ('UBERON_0000955', 'brain', 140, 'brain'), ('GO_0007567', 'parturition', 160, 'birth')]
S293-PMC3407995	PMC3407995	7/2012	S293-PMC3407995	['THERE IS EVIDENCE that Vitamin D during Pregnancy is INVOLVED in foetal Brain Development and that maternal Vitamin D deficiency during Pregnancy CAN alter the structure and function of the Brain resulting in Life long behavioural changes in the offspring [146,147,148].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 146)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0007420', 'brain development', 72, 'brain development'), ('UBERON_0000955', 'brain', 72, 'brain'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnancy'), ('UBERON_0000955', 'brain', 190, 'brain'), ('UBERON_0000104', 'life cycle', 209, 'life')]
S66-PMC3417531	PMC3417531	7/2012	S66-PMC3417531	"[""(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada's aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?""]"	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]
S16-PMC3424155	PMC3424155	8/2012	S16-PMC3424155	['HOWEVER, NEW EVIDENCE SUGGESTS that Vitamin D COULD BE VITAL to normal fetal Development and that Vitamin D restriction in this period MAY AFFECT chronic disease susceptibility post-Natal Life[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 139)]	7	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007567', 'parturition', 182, 'natal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
S23-PMC3424155	PMC3424155	8/2012	S23-PMC3424155	['THIS STUDY investigates the EFFECTS of maternal Vitamin D deficiency on Glomerular Development in early Postnatal Life and its EFFECTS on Renal structure at maturity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0032835', 'glomerulus development', 72, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 72, 'glomerular'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('UBERON_0000104', 'life cycle', 114, 'life'), ('UBERON_0002113', 'kidney', 138, 'renal')]
S26-PMC3427192	PMC3427192	4/2012	S26-PMC3427192	['similarly, in a finnish Birth cohort, infants supplemented with Vitamin D during the first year of Life were not more LIKELY to have asthma in early Adulthood.67rather, in that STUDY67AND another,68the prevalence of allergic sensitization was greater at age 6 and age 31 y in those subjects who received regular Vitamin D supplementation during infancy.']	[('PROBABLE_UNDERSTANDING', 118), ('INCOMPLETE_EVIDENCE', 177)]	2	[('GO_0007567', 'parturition', 24, 'birth'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000104', 'life cycle', 99, 'life'), ('UBERON_0000113', 'post-juvenile adult stage', 149, 'adulthood'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D')]
S28-PMC3427192	PMC3427192	4/2012	S28-PMC3427192	['studies of Vitamin D exposure in early Life and Respiratory outcomesauthoryearcountrystudy designsample sizeage of children at assessmentdetermination of Vitamin D statusassociation between Vitamin D and Respiratory outcomesbelderbos572011netherlandsprospective cohort156 neonatesbirth to 1 ymaternal Food-frequency questionnaire and Cord Blood 25(Oh)Dlower 25(Oh)D concentrations ASSOCIATED with an increased risk of Respiratory syncytial Virus infectioncamargo582007united statesprospective cohort1194 mother-child dyads3 ymaternal Food-frequency questionnairehighest quartile of Vitamin D intake during Pregnancy ASSOCIATED with a lower risk of recurrent wheezingcamargo592011new zealandprospective cohort922 newbornsbirth to 5 ycord Blood 25(Oh)Dhigher 25(Oh)D ASSOCIATED with a decreased risk of Respiratory infection and wheezing BUT NO associations with childhood asthma NOTEDCARROLL602011CANADACROSS-sectional340 mother-infant dyads5–29 weeksmaternal whole Blood 25(Oh)Dincreasing maternal 25(Oh)D ASSOCIATED with decreased odds of asthma in mothers BUT no associations with infantile wheezing noteddevereux612007scotlandprospective cohort2000 Pregnant women, 1212 children5 ymaternal Food-frequency questionnairehighest and lowest maternal Vitamin D intakes ASSOCIATED with lower risk of wheezingerkkola622009finlandprospective cohort1669 mother-child dyads5 ymaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with lower risk of asthma and allergic rhinitisgale632008ukprospective cohort466 mothers and 178 children9 mo and 9 ymaternal Serum 25(Oh)Dmaternal Vitamin D levels > 75 nmol/l ASSOCIATED with increased risk of atopic dermatitis and asthmamiyake642010japanprospective cohort763 mother-child dyads16–24 momaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with a decreased risk of wheeze and atopic dermatitismorales652012spainprospective cohort1724 children12 mo, 4–6 ymaternal plasma 25(Oh)Dincreased maternal 25(Oh)D ASSOCIATED with a decreased risk of lower Respiratory infections BUT NOT wheezing or asthmarothers662011united statesprospective cohort219 childrenbirth to 5 ycord Blood 25(Oh)Dboth low and high Cord Blood 25(Oh)D ASSOCIATED with increased Aeroallergen sensitization BUT NOT with allergic rhinitis or asthma\nin other Birth cohort studies where 25(Oh)D concentrations were measured in the Plasma and whole Blood of Pregnant women, median 25(Oh)D concentrations ranged from APPROXIMATELY 20 to 29.5 ng/ml.60,63,65a 50% decrease in the odds of maternal asthma was FURTHER OBSERVED with every 35 nmol/l increase in 25(Oh)D levels, SUGGESTING a POSSIBLE LINK between Vitamin D status and asthma during Pregnancy.60HOWEVER, similar to the studies of maternal Vitamin D intake, NO CONSISTENT RELATIONSHIPS between 25(Oh)D concentrations and Respiratory symptoms during childhood HAVE BEEN observed.']	[('SUPERFICIAL_RELATIONSHIP', 381), ('SUPERFICIAL_RELATIONSHIP', 616), ('SUPERFICIAL_RELATIONSHIP', 765), ('ANOMALY_CURIOUS_FINDING', 836), ('ANOMALY_CURIOUS_FINDING', 878), ('SUPERFICIAL_RELATIONSHIP', 1006), ('ANOMALY_CURIOUS_FINDING', 1058), ('SUPERFICIAL_RELATIONSHIP', 1267), ('SUPERFICIAL_RELATIONSHIP', 1439), ('SUPERFICIAL_RELATIONSHIP', 1627), ('SUPERFICIAL_RELATIONSHIP', 1824), ('SUPERFICIAL_RELATIONSHIP', 1999), ('ANOMALY_CURIOUS_FINDING', 2064), ('SUPERFICIAL_RELATIONSHIP', 2213), ('ANOMALY_CURIOUS_FINDING', 2266), ('INCOMPLETE_EVIDENCE', 2471), ('INCOMPLETE_EVIDENCE', 2560), ('INCOMPLETE_EVIDENCE', 2568), ('INCOMPLETE_EVIDENCE', 2626), ('INCOMPLETE_EVIDENCE', 2639), ('SUPERFICIAL_RELATIONSHIP', 2648), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2706), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2770), ('SUPERFICIAL_RELATIONSHIP', 2784), ('INCOMPLETE_EVIDENCE', 2871)]	25	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 39, 'life'), ('UBERON_0001004', 'respiratory system', 48, 'respiratory'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 204, 'respiratory'), ('CHEBI_33290', 'food', 301, 'food'), ('UBERON_0002240', 'spinal cord', 334, 'cord'), ('UBERON_0000178', 'blood', 339, 'blood'), ('CHEBI_78858', '(R)-2-methylpyrrolidine', 345, '25(OH)DLower'), ('CHEBI_71657', 'versiconol acetate', 358, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 418, 'respiratory'), ('NCBITaxon_1', 'root', 440, 'virus'), ('CHEBI_33290', 'food', 534, 'food'), ('CHEBI_27300', 'vitamin D', 582, 'vitamin D'), ('GO_0007565', 'female pregnancy', 606, 'pregnancy'), ('UBERON_0000178', 'blood', 737, 'blood'), ('CHEBI_72842', '9-oxo-ODE', 743, '25(OH)DHigher'), ('CHEBI_71657', 'versiconol acetate', 757, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 801, 'respiratory'), ('UBERON_0000178', 'blood', 965, 'blood'), ('CHEBI_74350', 'N-diazoacetylnorleucine methyl ester', 971, '25(OH)DIncreasing'), ('PR_000011614', 'opioid growth factor receptor', 974, 'OH'), ('PR_000006449', 'diacylglycerol kinase kappa', 977, 'DIncreasing'), ('CHEBI_71657', 'versiconol acetate', 998, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 998, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 1152, 'pregnant'), ('CHEBI_33290', 'food', 1193, 'food'), ('CHEBI_27300', 'vitamin D', 1249, 'vitamin D'), ('CHEBI_33290', 'food', 1378, 'food'), ('CHEBI_27300', 'vitamin D', 1422, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1576, 'serum'), ('CHEBI_51469', 'butyllithium', 1582, '25(OH)DMaternal'), ('CHEBI_27300', 'vitamin D', 1598, 'vitamin D'), ('CHEBI_33290', 'food', 1763, 'food'), ('CHEBI_27300', 'vitamin D', 1807, 'vitamin D'), ('CHEBI_86378', '(25R)-3beta-hydroxycholest-5-en-26-oic acid', 1965, '25(OH)DIncreased'), ('PR_000011040', 'nuclear receptor coactivator 1', 1967, '(OH'), ('CHEBI_71657', 'versiconol acetate', 1991, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1991, '25(OH ... D'), ('UBERON_0001004', 'respiratory system', 2041, 'respiratory'), ('UBERON_0000178', 'blood', 2163, 'blood'), ('CHEBI_73803', 'Ala-Asp', 2169, '25(OH)DBoth'), ('UBERON_0002240', 'spinal cord', 2194, 'cord'), ('UBERON_0000178', 'blood', 2199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 2205, '25(OH)D'), ('CHEBI_2500', 'Aescin', 2239, 'aeroallergen'), ('GO_0007567', 'parturition', 2316, 'birth'), ('CHEBI_71657', 'versiconol acetate', 2343, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 2387, 'plasma'), ('UBERON_0000178', 'blood', 2404, 'blood'), ('GO_0007565', 'female pregnancy', 2413, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 2436, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 2610, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 2616, 'D'), ('CHEBI_27300', 'vitamin D', 2661, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2696, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2752, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 2806, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 2833, 'respiratory')]
S32-PMC3427192	PMC3427192	4/2012	S32-PMC3427192	['HOWEVER, in THESE STUDIES, there were no associations between Cord-Blood 25(Oh)D concentrations and subsequent asthma at 5 y of age.59,66\ncollectively, these studies SUGGEST that the benefits of Vitamin D during early Life MAY BE LIMITED to its EFFECTS on Respiratory infections and Viral-induced wheezing and not asthma per se.17HOWEVER, ALTHOUGH Vitamin D MAY have IMPORTANT ROLES in Immune Regulation during early Life, excessive Vitamin D exposure MAY also be ASSOCIATED with adverse health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 328), ('ANOMALY_CURIOUS_FINDING', 339), ('INCOMPLETE_EVIDENCE', 358), ('IMPORTANT_CONSIDERATION', 367), ('SUPERFICIAL_RELATIONSHIP', 377), ('INCOMPLETE_EVIDENCE', 452), ('SUPERFICIAL_RELATIONSHIP', 464)]	13	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('UBERON_0000104', 'life cycle', 218, 'life'), ('UBERON_0001004', 'respiratory system', 256, 'respiratory'), ('NCBITaxon_1', 'root', 283, 'viral'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0002521', 'leukocyte differentiation', 386, 'immune regulation'), ('UBERON_0002405', 'immune system', 386, 'immune'), ('UBERON_0000104', 'life cycle', 417, 'life'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D')]
S35-PMC3427192	PMC3427192	4/2012	S35-PMC3427192	['HOWEVER, it is IMPORTANT TO NOTE that a large percentage of children were lost to follow-up, and THUS the resulting sample of mothers had higher concentrations of 25(Oh)D and were older, less LIKELY to smoke during Pregnancy, and more educated.63therefore WHILE there MAY BE therapeutic window for vitamin D supplementation in early Life, FURTHER STUDIES ARE NEEDED to more clearly understand the RISKS of high Vitamin D intake and bioavailability during the early childhood years.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 192), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 268), ('FUTURE_WORK', 339), ('FUTURE_WORK', 347), ('IMPORTANT_CONSIDERATION', 397)]	9	[('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 306, 'D'), ('UBERON_0000104', 'life cycle', 333, 'life'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D')]
S67-PMC3427192	PMC3427192	4/2012	S67-PMC3427192	['conclusion\nthere is a GROWING INTEREST in the ROLE of Vitamin D in asthma and Respiratory disorders across the Lifespan.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 78, 'respiratory'), ('UBERON_0000104', 'life cycle', 111, 'lifespan')]
S70-PMC3427192	PMC3427192	4/2012	S70-PMC3427192	['BECAUSE of the LIMITATIONS of OBSERVATIONAL studies which include CONFOUNDING by indication, definitive RECOMMENDATIONS for Vitamin D in subjects with asthma across the Lifespan cannot be made.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 66), ('FUTURE_WORK', 104)]	5	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0000104', 'life cycle', 169, 'lifespan')]
S13-PMC3472720	PMC3472720	8/2012	S13-PMC3472720	['in this MODEL, the Vitamin D deficiency experienced by the offspring is restored by the 1st week of Life, therefore the MODEL is not associated with any abnormal Bone Development and calcium and pth levels in the Adult offspring are normal [13].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 120)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('GO_0048539', 'bone marrow development', 162, 'bone development'), ('UBERON_0007023', 'adult organism', 213, 'adult')]
S105-PMC3509518	PMC3509518	11/2012	S105-PMC3509518	['furthermore, maternal dietary Vitamin C intake in Pregnancy APPEARED PROTECTIVE against Development Of Wheeze in the first year of Life.']	[('ANOMALY_CURIOUS_FINDING', 60), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin C'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0060041', 'retina development in camera-type eye', 88, 'development of wheeze'), ('UBERON_0000104', 'life cycle', 131, 'life')]
S154-PMC3515553	PMC3515553	12/2012	S154-PMC3515553	['YET, LITTLE IS KNOWN about the INFLUENCE that low Plasma Vitamin B-12 during Pregnancy MAY have on the Cognitive ability of children later in Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 87)]	4	[('UBERON_0001969', 'blood plasma', 50, 'plasma'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 57, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0050890', 'cognition', 103, 'cognitive'), ('UBERON_0000104', 'life cycle', 142, 'life')]
S187-PMC3613945	PMC3613945	2/2013	S187-PMC3613945	['REPORTED no association between ultraviolet radiation (uvr) or Vitamin D Serum levels; YET, cod Liver oil supplementation earlier in Life was ASSOCIATED with an INCREASED risk of asthma112.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 87), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 161)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001977', 'blood serum', 73, 'serum'), ('UBERON_0002107', 'liver', 96, 'liver'), ('UBERON_0000104', 'life cycle', 133, 'life')]
S68-PMC3629265	PMC3629265	4/2013	S68-PMC3629265	['it SEEMS UNLIKELY that infants in the first few months of Life would drink 2 l of formula/day, the volume NECESSARY to receive 800 iu/day of Vitamin D. four of our cases presented during the autumn and winter months, the other two infants presented during the early spring.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('IMPORTANT_CONSIDERATION', 106)]	3	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
S71-PMC3629265	PMC3629265	4/2013	S71-PMC3629265	['a RECENT telephone survey of mothers of full-term infants in montreal IDENTIFIED that infants Consuming mixed Feedings (Breast and formula) and those exclusively formula-Fed were at high risk of not meeting recommended Vitamin D intake in the first 6 months of Life (25).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 70)]	2	[('GO_0007631', 'feeding behavior', 94, 'consuming'), ('GO_0007631', 'feeding behavior', 110, 'feedings'), ('UBERON_0000310', 'breast', 120, 'breast'), ('GO_0007631', 'feeding behavior', 170, 'fed'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('UBERON_0000104', 'life cycle', 261, 'life')]
S26-PMC3651971	PMC3651971	5/2013	S26-PMC3651971	['in a study of healthy chinese mothers and newborns, a positive RELATIONSHIP was OBSERVED between Cord Blood Retinol level and motor skill achievements by age 2.17in indonesia, newborn Vitamin A supplementation resulted in modest improvement in Motor Development scores after 3\u2005years,18while Vitamin A supplementation to hiv-positive tanzanian women exerted no detectable changes in infant Psychomotor Development.19there REMAINS, HOWEVER, a NEED FOR ADDITIONAL causal data on early Life Vitamin A exposure and Neurocognitive and motor function.']	[('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 421), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 430), ('FUTURE_WORK', 441)]	5	[('UBERON_0002240', 'spinal cord', 97, 'cord'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_26536', 'retinoic acid', 108, 'retinol'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 244, 'motor development'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin A'), ('GO_0030324', 'lung development', 389, 'psychomotor development'), ('UBERON_0000104', 'life cycle', 482, 'life'), ('CHEBI_27300', 'vitamin D', 487, 'vitamin A'), ('GO_0050905', 'neuromuscular process', 510, 'neurocognitive')]
S142-PMC3651971	PMC3651971	5/2013	S142-PMC3651971	['the Human studies that have SUGGESTED a ROLE for Vitamin A in Cognitive and Motor Development are LIMITED to much younger children.1718another POSSIBLE EXPLANATION for our results is that differences between groups were attenuated by routine supplementation from the national Vitamin A programme started in 1995.30given the wide cis for experimental measures of Cognitive and motor development, and the POTENTIAL for Brain plasticity, the supplementation programme MIGHT have attenuated a treatment EFFECT, allowing placebo group children to regain the nutritional losses of their early Life.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 152), ('INCOMPLETE_EVIDENCE', 403), ('INCOMPLETE_EVIDENCE', 465), ('SUPERFICIAL_RELATIONSHIP', 499)]	8	[('NCBITaxon_9606', 'Homo sapiens', 4, 'human'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('GO_0050890', 'cognition', 62, 'cognitive ...'), ('GO_0009653', 'anatomical structure morphogenesis', 76, 'motor development'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A'), ('GO_0050890', 'cognition', 362, 'cognitive'), ('UBERON_0000955', 'brain', 417, 'brain'), ('UBERON_0000104', 'life cycle', 587, 'life')]
S131-PMC3659910	PMC3659910	1/2013	S131-PMC3659910	['RESEARCH has FOUND direct CONNECTIONS between Vitamin D and the Genes KNOWN to be INVOLVED in ms, BUT exact pathology and WHETHER Vitamin D supplements during Pregnancy OR childhood can lessen the likelihood of the child developing ms later in Life is NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 82), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('FULL_UNKNOWN', 252)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genes'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy'), ('UBERON_0000104', 'life cycle', 244, 'life')]
S175-PMC3659910	PMC3659910	1/2013	S175-PMC3659910	['a RECENT systematic review CONCLUDED that Antenatal Vitamin D supplementation is EFFECTIVE in improving the Vitamin D status of asian and white women, improves growth in the first year of Life in south asian babies and THEREFORE MAY CONTRIBUTE to reducing the incidence of rickets in this latter group, without evidence of harm.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 81), ('PROBABLE_UNDERSTANDING', 219), ('FUTURE_PREDICTION', 229), ('SUPERFICIAL_RELATIONSHIP', 233)]	6	[('GO_0007567', 'parturition', 42, 'antenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000104', 'life cycle', 188, 'life')]
S194-PMC3659910	PMC3659910	1/2013	S194-PMC3659910	"['FUTURE STUDIES are ESSENTIAL to determine the true Vitamin D REQUIREMENT during Pregnancy NOT ONLY for maternal Skeletal preservation and fetal Skeletal Formation, BUT ALSO for fetal “Imprinting"" that MAY AFFECT Neurodevelopment, Immune function and chronic disease SUSCEPTIBILITY soon after Birth as well as later in Life.']"	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 90), ('FUTURE_PREDICTION', 201), ('SUPERFICIAL_RELATIONSHIP', 205), ('IMPORTANT_CONSIDERATION', 266)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0004288', 'skeleton', 112, 'skeletal'), ('GO_0001501', 'skeletal system development', 144, 'skeletal formation'), ('UBERON_0004288', 'skeleton', 144, 'skeletal'), ('GO_0071514', 'genetic imprinting', 184, 'imprinting'), ('GO_0007399', 'nervous system development', 212, 'neurodevelopment'), ('UBERON_0002405', 'immune system', 230, 'immune'), ('GO_0007567', 'parturition', 292, 'birth'), ('UBERON_0000104', 'life cycle', 318, 'life')]
S28-PMC3668200	PMC3668200	5/2013	S28-PMC3668200	['Breast Milk ALONE can meet the Nutrient REQUIREMENT during the first 6 months of Life, with the POSSIBLE EXCEPTION of Vitamin D. the Vitamin A and Vitamin E contents of the Breast Milk are CORRELATED with the amount of the Vitamins in the dietary intake of Lactating mothers.']	[('ANOMALY_CURIOUS_FINDING', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 96), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 189)]	5	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_33284', 'nutrient', 31, 'nutrient'), ('UBERON_0000104', 'life cycle', 81, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin E'), ('UBERON_0001348', 'brown adipose tissue', 173, 'breast milk'), ('CHEBI_33277', 'gamma-tocotrienol', 223, 'vitamins'), ('GO_0007594', 'puparial adhesion', 257, 'lactating')]
S0-PMC3672018	PMC3672018	5/2013	S0-PMC3672018	['the INFLUENCE of early exposure to Vitamin D for development of Diseases later in Life\n\nabstract\n\nbackground\nVitamin D deficiency is common among otherwise healthy Pregnant women and MAY have CONSEQUENCES for them as well as the early Development and long-term health Of their Children.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 183), ('IMPORTANT_CONSIDERATION', 192)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007586', 'digestion', 64, 'diseases'), ('UBERON_0000104', 'life cycle', 82, 'life'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnant'), ('GO_0001709', 'cell fate determination', 235, 'development ... - ... of ... children')]
S1-PMC3672018	PMC3672018	5/2013	S1-PMC3672018	['HOWEVER, the IMPORTANCE of maternal Vitamin D status on offspring health later in Life has not been widely studied.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 82, 'life')]
S2-PMC3672018	PMC3672018	5/2013	S2-PMC3672018	['the PRESENT STUDY includes an in-depth examination of the INFLUENCE of exposure to Vitamin D early in Life for development of fractures of the Wrist, Arm and Clavicle; obesity, and type 1 diabetes (t1d) during child- and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000104', 'life cycle', 102, 'life'), ('UBERON_0004452', 'carpal region', 143, 'wrist'), ('UBERON_0001460', 'arm', 150, 'arm'), ('UBERON_0001105', 'clavicle bone', 158, 'clavicle'), ('UBERON_0000113', 'post-juvenile adult stage', 221, 'adulthood')]
S4-PMC3672018	PMC3672018	5/2013	S4-PMC3672018	['apart from determining the INFLUENCES of exposure prior to Conception and during Prenatal Life, we will EXAMINE the IMPORTANCE of Vitamin D exposure during specific seasons and trimesters, by comparing disease incidence among Individuals Born before and after fortification.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 104), ('IMPORTANT_CONSIDERATION', 116)]	3	[('GO_0007620', 'copulation', 59, 'conception'), ('GO_0007565', 'female pregnancy', 81, 'prenatal'), ('UBERON_0000104', 'life cycle', 90, 'life'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('NCBITaxon_1', 'root', 226, 'individuals'), ('GO_0007567', 'parturition', 238, 'born')]
S20-PMC3672018	PMC3672018	5/2013	S20-PMC3672018	['low Vitamin D during Gestation and in early Life MAY THEREFORE play an IMPORTANT ROLE for susceptibility to bone fragility, obesity and Autoimmune diseases later in Life [6].']	[('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 53), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 21, 'gestation'), ('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0001442', 'skeleton of manus', 136, 'autoimmune'), ('UBERON_0000104', 'life cycle', 165, 'life')]
S27-PMC3672018	PMC3672018	5/2013	S27-PMC3672018	['importance of fetal Vitamin D on health later in Life\nVitamin D insufficiency is highly PREVALENT in both developed and developing societies.']	[('IMPORTANT_CONSIDERATION', 88)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0000104', 'life cycle', 49, 'life'), ('CHEBI_28384', 'vitamin K', 54, 'Vitamin D')]
S36-PMC3672018	PMC3672018	5/2013	S36-PMC3672018	['to date, the RELATIONSHIP between Vitamin D status during fetal Life and long-term health has not been widely examined, and interventions are generally lacking.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0000104', 'life cycle', 64, 'life')]
S50-PMC3672018	PMC3672018	5/2013	S50-PMC3672018	['this allows for the examination of the EFFECTS of exposure to additional Vitamin D via fortified Foods during fetal Life in RELATION to later development of particular diseases.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 124)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_33290', 'food', 97, 'foods'), ('UBERON_0000104', 'life cycle', 116, 'life')]
S56-PMC3672018	PMC3672018	5/2013	S56-PMC3672018	['the Vitamin D fortification of low fat milk was not mandatory and THEREFORE not all low fat Milk distributed in denmark in the time period was fortified with Vitamin D. UNFORTUNATELY, there are no national statistics INDICATING the proportion of Milk Consumed that was fortified with Vitamin D. NEVERTHELESS, the two well-defined time periods of Vitamin D fortification provide a natural framework for comparing the EFFECTS of early exposure to Vitamin D on the Development Of Diseases later in Life amongst exposed and non-exposed adjacent Birth cohorts (figure\xa01).']	[('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 169), ('INCOMPLETE_EVIDENCE', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('SUPERFICIAL_RELATIONSHIP', 416)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0001913', 'milk', 92, 'milk'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001913', 'milk', 246, 'milk'), ('GO_0007631', 'feeding behavior', 251, 'consumed'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0009603', 'detection of symbiotic fungus', 462, 'development of diseases'), ('UBERON_0000104', 'life cycle', 495, 'life'), ('GO_0007567', 'parturition', 541, 'birth')]
S82-PMC3672018	PMC3672018	5/2013	S82-PMC3672018	['in the FUTURE, a third phase will be PLANNED and will examine ASSOCIATION between additional exposure to Vitamin D in fetal Life and later development of other Immunological disorders, including severe asthma, crohn’s disease, Inflammatory Bowel diseases, and juvenile idiopathic arthritis.']	[('FUTURE_WORK', 7), ('FUTURE_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life'), ('UBERON_0003222', 'flexor digitorum superficialis', 160, 'immunological'), ('UBERON_0001782', 'pigmented layer of retina', 227, 'inflammatory bowel')]
S96-PMC3672018	PMC3672018	5/2013	S96-PMC3672018	['LIKEWISE, Individuals Born 1–2\u2009years after mandatory fortification terminated in 1985, and who were unexposed to Vitamin D both during Fetal Development and subsequently, will have a higher risk of later developing the diseases COMPARED TO those exposed during fetal Life.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	2	[('NCBITaxon_1', 'root', 10, 'individuals'), ('GO_0007567', 'parturition', 22, 'born'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 135, 'fetal development'), ('UBERON_0000104', 'life cycle', 267, 'life')]
S173-PMC3672018	PMC3672018	5/2013	S173-PMC3672018	['Human intervention studies to determine the level of Vitamin D supplementation NECESSARY to reduce susceptibility to diseases later in Life and concomitant basic research exploring the biological mechanisms that may be INVOLVED.']	[('IMPORTANT_CONSIDERATION', 79), ('SUPERFICIAL_RELATIONSHIP', 219)]	2	[('NCBITaxon_9606', 'Homo sapiens', 0, 'human'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000104', 'life cycle', 135, 'life')]
S175-PMC3672018	PMC3672018	5/2013	S175-PMC3672018	['Growth and Pubertal Development, POSSIBILITY RELATED to Vitamin D exposures in early Life, PERHAPS EVEN before Conception, in addition to the outcomes studied.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 91), ('ANOMALY_CURIOUS_FINDING', 99)]	4	[('GO_0040007', 'growth', 0, 'growth ...'), ('GO_0060021', 'roof of mouth development', 11, 'pubertal development'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000104', 'life cycle', 85, 'life'), ('GO_0007620', 'copulation', 111, 'conception')]
S178-PMC3672018	PMC3672018	5/2013	S178-PMC3672018	['it THUS allows examination of the EFFECTS of low Vitamin D during fetal Life in RELATION to later development of particular diseases.']	[('PROBABLE_UNDERSTANDING', 3), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life')]
S19-PMC3685533	PMC3685533	6/2013	S19-PMC3685533	['RISK FACTORS for Vitamin D deficiency and rickets in early Life include Breast-Feeding without Vitamin D supplementation, dark skin pigmentation, season, latitude and maternal Vitamin d deficiency [1].']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0000104', 'life cycle', 59, 'life'), ('GO_0007567', 'parturition', 72, 'breast'), ('GO_0007631', 'feeding behavior', 79, 'feeding'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 176, 'vitamin')]
S22-PMC3685533	PMC3685533	6/2013	S22-PMC3685533	['in utero, the fetus is wholly dependent on the mother for Vitamin D. the 25Ohd crosses the Placenta into the Blood stream of the fetus with a half-Life of APPROXIMATELY 2 months [7].']	[('INCOMPLETE_EVIDENCE', 155)]	1	"[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 73, '25OHD'), ('UBERON_0001987', 'placenta', 91, 'placenta'), ('UBERON_0000178', 'blood', 109, 'blood'), ('UBERON_0000104', 'life cycle', 147, 'life')]"
S35-PMC3685533	PMC3685533	6/2013	S35-PMC3685533	['IN ORDER TO understand the DIFFERENCES in Vitamin D levels depending on skin colour and ethnic differences, we evaluated 25Ohd levels at Birth in Cord Blood and in the first three days of Life from ethnically diverse infants Born within our hospital.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27)]	2	"[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 121, '25OHD'), ('GO_0007567', 'parturition', 137, 'birth'), ('UBERON_0002240', 'spinal cord', 146, 'cord'), ('UBERON_0000178', 'blood', 151, 'blood'), ('UBERON_0000104', 'life cycle', 188, 'life'), ('GO_0007567', 'parturition', 225, 'born')]"
S92-PMC3685533	PMC3685533	6/2013	S92-PMC3685533	['at three days of Life, Vitamin D values were higher in itan ONLY when compared with nan (p\u2009<\u20090.03).']	[('ANOMALY_CURIOUS_FINDING', 60)]	1	[('UBERON_0000104', 'life cycle', 17, 'life'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
S22-PMC3691177	PMC3691177	6/2013	S22-PMC3691177	['we assessed children whose mothers had taken part in a randomised controlled trial of Prenatal Vitamin D supplementation, TO DETERMINE WHETHER supplementation PREVENTED wheezing or allergic disease in the first 3 years of Life[19].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('GO_0007565', 'female pregnancy', 86, 'prenatal'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000104', 'life cycle', 222, 'life')]
S107-PMC3691177	PMC3691177	6/2013	S107-PMC3691177	['discussion\nin THIS randomised CONTROLLED TRIAL of Vitamin D supplementation in late Pregnancy in a relatively deficient mixed race population, daily supplementation with 800 iu Ergocalciferol or a single bolus dose of 200,000 iu Cholecalciferol from 27 weeks Gestation did not prevent wheezing, allergic disease or influence measures of Lung function or allergic inflammation in offspring in the first three years of Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_4910', 'etomidate', 177, 'ergocalciferol'), ('CHEBI_52550', 'theopalauamide', 229, 'cholecalciferol'), ('GO_0007565', 'female pregnancy', 259, 'gestation'), ('UBERON_0002048', 'lung', 337, 'lung'), ('UBERON_0000104', 'life cycle', 417, 'life')]
S138-PMC3691177	PMC3691177	6/2013	S138-PMC3691177	['IN SUMMARY we FOUND NO EVIDENCE for a protective effect of Prenatal Vitamin D supplementation from 27 weeks Gestation on childhood wheezing, allergic disease, Lung function or markers of Airway inflammation in the first 3 years of Life.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 20)]	3	[('GO_0007565', 'female pregnancy', 59, 'prenatal'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'gestation'), ('UBERON_0002048', 'lung', 159, 'lung'), ('UBERON_0001005', 'respiratory airway', 187, 'airway'), ('UBERON_0000104', 'life cycle', 231, 'life')]
S61-PMC3695234	PMC3695234	7/2013	S61-PMC3695234	['camargo et al.13found no decreased risk of ad in the children of mothers with higher intakes of Vitamin D. a northern finland Birth cohort INDICATED the ASSOCIATION between Vitamin D supplementation in the first year of Life and an increased risk of atopy at age 31 years.14a FURTHER prospective study REPORTED that an increased concentration of 25(Oh)D3In maternal Serum predisposed infants to ad at 9 months of age.15these variable results MAY BE secondary to the differences in the absolute amount of Vitamin D exposure, the baseline Vitamin D status, and the timing of exposure.']	[('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 153), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 302), ('INCOMPLETE_EVIDENCE', 442)]	5	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('UBERON_0000104', 'life cycle', 220, 'life'), ('PR_000001883', 'lysosome-associated membrane protein', 346, '25(OH)D3in'), ('UBERON_0001977', 'blood serum', 366, 'serum'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 537, 'vitamin D')]
S54-PMC3702245	PMC3702245	6/2013	S54-PMC3702245	['Monocytes cultured in Vitamin D-deficient Plasma (Serum 25(Oh)D < 30 nmol/l) SHOWED significantly decreased Tolllike Receptor-mediated Expression of Cathelicidin (p < 0.05) compared with those conditioned in Vitamin D-sufficient Plasma (Serum 25(Oh)D > 75 nmol/l).93CONSISTENT with these in vitro FINDINGS, OBSERVATIONAL clinical DATA FOUND an ASSOCIATION between Vitamin D status in Cord Blood and the RISK of Lower Respiratory Tract infection in the first year of Life.94the risk of Respiratory syncytial Virus bronchiolitis in the first year of Life is increased by six-fold (ci 1.6–24.9) in infants with Cord Blood 25(Oh)D < 50 nmol/l compared with infants with 25(Oh)D > 75 nmol/l.']	[('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('INCOMPLETE_EVIDENCE', 297), ('INCOMPLETE_EVIDENCE', 307), ('FUTURE_WORK', 330), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 344), ('IMPORTANT_CONSIDERATION', 403)]	9	[('CL_0000576', 'monocyte', 0, 'Monocytes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000001660', 'prostaglandin F2-alpha receptor', 108, 'tolllike receptor'), ('GO_0010467', 'gene expression', 135, 'expression'), ('PR_000006009', 'alpha-catulin', 149, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 229, 'plasma'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 384, 'cord'), ('UBERON_0000178', 'blood', 389, 'blood'), ('UBERON_0004905', 'articulation', 411, 'lower respiratory tract'), ('UBERON_0000104', 'life cycle', 466, 'life'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory'), ('NCBITaxon_1', 'root', 507, 'virus'), ('UBERON_0000104', 'life cycle', 548, 'life'), ('UBERON_0002240', 'spinal cord', 608, 'cord'), ('UBERON_0000178', 'blood', 613, 'blood'), ('CHEBI_71657', 'versiconol acetate', 619, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 619, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 666, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 666, '25(OH)D')]
S48-PMC3713405	PMC3713405	7/2013	S48-PMC3713405	['schizophrenia HAS BEEN SHOWN to be ameliorated by Vitamin D supplementation in the 1 year of Life (mcgrath et al., 2004).']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0000104', 'life cycle', 93, 'life')]
S68-PMC3717170	PMC3717170	5/2013	S68-PMC3717170	['Vitamin D during Pregnancy and Lactation\nVitamin D as a preprohormone has EFFECTS that extend beyond Calcium Metabolism and Homeostasis throughout Life but which are most vivid during Pregnancy when Vitamin D Metabolism is disengaged from its usual constraints.12at no other time during the Lifecycle is 25(Oh)D3Linked directly to 1,25(Oh)2d3production, the latter rising more than 2.5 times above nonpregnant levels.12this elevation of 1,25(oh)2d3likely serves the purpose of Immune Regulation, THOUGH there HAVE BEEN ONLY a FEW STUDIES that have evaluated the EFFECT of Vitamin D status on Immune function during Pregnancy to SUPPORT THIS HYPOTHESIS.']	[('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 484), ('ANOMALY_CURIOUS_FINDING', 496), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 628), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 641)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('GO_0007595', 'lactation', 31, 'lactation'), ('CHEBI_28384', 'vitamin K', 41, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 101, 'calcium metabolism'), ('GO_0042592', 'homeostatic process', 124, 'homeostasis'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 199, 'vitamin D metabolism'), ('UBERON_0000104', 'life cycle', 291, 'lifecycle'), ('CHEBI_77914', '3-methylbut-1-ene', 304, '25(OH)D3linked'), ('CHEBI_63056', 'zinc cation', 333, '25(OH'), ('CHEBI_17996', 'chloride', 438, ','), ('GO_0002521', 'leukocyte differentiation', 477, 'immune regulation'), ('UBERON_0002405', 'immune system', 477, 'immune'), ('CHEBI_27300', 'vitamin D', 572, 'vitamin D'), ('UBERON_0002405', 'immune system', 592, 'immune'), ('GO_0007565', 'female pregnancy', 615, 'pregnancy')]
S9-PMC3717763	PMC3717763	8/2013	S9-PMC3717763	['this scheme provides low-income families in the uk with fixed-value Food vouchers and vitamin coupons for eligible women and young children.1vitamin coupons can be exchanged for branded hs vitamin tablets for women (70\u2005mg Vitamin C, 10\u2005µg Vitamin D and 400\u2005µg Folic Acid daily during Pregnancy, and one year Postpartum) and drops for children (233\u2005µg Vitamin A, 20\u2005µg Vitamin C, and 7.5\u2005µg Vitamin D3 daily between\n\ncaption (boxed-text)\nwhat is already known on THIS topic\ncurrent uk GUIDANCE is that vulnerable groups of Pregnant and breastfeeding women and young children SHOULD take Vitamin Supplements (including Vitamins A, c and d) to protect against the greater RISK of Birth defects and poor health outcomes in later Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 462), ('FUTURE_WORK', 484), ('FUTURE_WORK', 574), ('IMPORTANT_CONSIDERATION', 669)]	4	[('CHEBI_33290', 'food', 68, 'food'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('CHEBI_30751', 'formic acid', 260, 'folic acid'), ('GO_0007565', 'female pregnancy', 284, 'pregnancy'), ('GO_0007565', 'female pregnancy', 308, 'postpartum'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin C'), ('CHEBI_33279', 'vitamin D5', 390, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 390, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 522, 'pregnant'), ('CHEBI_33229', 'vitamin (role)', 586, 'vitamin'), ('CHEBI_33341', 'titanium atom', 594, 'supplements'), ('CHEBI_27300', 'vitamin D', 617, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 626, 'A'), ('GO_0007567', 'parturition', 677, 'birth'), ('UBERON_0000104', 'life cycle', 725, 'life')]
S320-PMC3728489	PMC3728489	7/2013	S320-PMC3728489	['the american academy of pediatrics RECOMMENDS that all breastfed infants receive a daily Vitamin D supplement of 400 iu, beginning in the first few days of Life (wagner et al.,2008).']	[('FUTURE_WORK', 35)]	1	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000104', 'life cycle', 156, 'life')]
S67-PMC3773018	PMC3773018	4/2013	S67-PMC3773018	['we also FOUND high proportions of children with low Vitamin D status (i.e., <30ng.ml) during the first year of Life, 1–2 years, and 2–3 years (i.e., 29%, 36%, and 40%).']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000104', 'life cycle', 111, 'life')]
S75-PMC3773018	PMC3773018	4/2013	S75-PMC3773018	['children who had very low Vitamin D status at Birth but had sufficient Vitamin D during their early Life had no risk or a lower RISK of fs; WHILE children who were exposed to persistently low Vitamin D both pre- and post-Natally had the highest risk of fa (table 3).']	[('IMPORTANT_CONSIDERATION', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'natally')]
S116-PMC3798907	PMC3798907	8/2013	S116-PMC3798907	['on the one hand, the POSSIBLE therapeutic use of Vitamin E to help produce a “balanced” Th-Cell profile in early Life is SUPPORTED by the FINDING that supplementation of cbmc with this Nutrient GENERALLY inhibited cytokines characteristic of Th Effector Responses, including both th1 (Ifn-Γ) and th2 (il-4) cytokines.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 138), ('PROBABLE_UNDERSTANDING', 194)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin E'), ('CL_0000545', 'T-helper 1 cell', 88, 'Th-cell'), ('UBERON_0000104', 'life cycle', 113, 'life'), ('CHEBI_33284', 'nutrient', 185, 'nutrient'), ('GO_0007596', 'blood coagulation', 242, 'Th ... responses'), ('CHEBI_35224', 'effector', 245, 'effector'), ('PR_000008920', 'interferon alpha-7', 285, 'IFN-γ')]
S68-PMC3991049	PMC3991049	11/2013	S68-PMC3991049	['SEVERAL STUDIES have REPORTED ASSOCIATION between infant size and Vitamin D status.13,14reduced concentration of 25-Hydroxyvitamin D in mothers during late Pregnancy is ASSOCIATED with reduced Whole Body and Lumbar-Spine bone Mineral content in their children at the age of 9 years.15several studies HYPOTHESIZED that low Prenatal and Perinatal Vitamin D concentrations AFFECT the functional characteristics of various Tissues of the body, which leads to greater risk in later Life of multiple sclerosis, cancer, Insulin-dependent diabetes mellitus and schizophrenia.16,17\nthe current RECOMMENDED dose of Vitamin D during Pregnancy DIFFERS in DIFFERENT parts of the world.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 300), ('SUPERFICIAL_RELATIONSHIP', 370), ('FUTURE_WORK', 585), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 632), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643)]	9	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 113, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('UBERON_0000468', 'multicellular organism', 193, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 208, 'lumbar-spine'), ('CHEBI_46662', 'mineral', 226, 'mineral'), ('GO_0007565', 'female pregnancy', 322, 'prenatal'), ('GO_0036268', 'swimming', 335, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 335, 'perinatal'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0000479', 'tissue', 419, 'tissues'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('PR_000045358', 'insulin family protein', 513, 'insulin'), ('CHEBI_27300', 'vitamin D', 605, 'vitamin D'), ('GO_0007565', 'female pregnancy', 622, 'pregnancy')]
S4-PMC4045304	PMC4045304	2/2014	S4-PMC4045304	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
S133-PMC4045304	PMC4045304	2/2014	S133-PMC4045304	['a GROWING body of LITERATURE SUGGESTS that certain modifiable RISK FACTORS such as maternal Metabolic syndrome and certain Vitamins such as Vitamin D and Folic Acid either in utero or early Life, MAY BE ASSOCIATED with increased risk of autism [43–45].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 203)]	5	[('GO_0008152', 'metabolic process', 92, 'metabolic'), ('CHEBI_33277', 'gamma-tocotrienol', 123, 'vitamins'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_30751', 'formic acid', 154, 'folic acid'), ('UBERON_0000104', 'life cycle', 190, 'life')]
S184-PMC4045304	PMC4045304	2/2014	S184-PMC4045304	['there is a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK of autism.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life')]
S128-PMC4072587	PMC4072587	6/2014	S128-PMC4072587	['PREVIOUS authors have SUGGESTED that accelerated growth in length MAY occur during an infant’s first year of Life in infants Born to mothers with Vitamin D <30 nmol/l, as infant Vitamin D levels increase Postnatally, through post-Natal Vitamin D supplementation[5].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 66)]	3	[('UBERON_0000104', 'life cycle', 109, 'life'), ('GO_0007567', 'parturition', 125, 'born'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'postnatally'), ('GO_0007567', 'parturition', 230, 'natal'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
S36-PMC4106226	PMC4106226	7/2014	S36-PMC4106226	['OF INTEREST, asthmatic children had less exposure to sunlight and ate a diet less rich in Vitamin D. this MAY INDICATE that asthma Control MAY benefit from a healthier Life-style and a Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 139)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0065007', 'biological regulation', 131, 'control'), ('UBERON_0000104', 'life cycle', 168, 'life'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
S484-PMC4113768	PMC4113768	7/2014	S484-PMC4113768	['background: Vitamin D MAY INFLUENCE Tissue Modelling and Repair in the Lungs throughout Life and THUS low levels of Vitamin D MAY have a negative IMPACT on Lung function.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 26), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 146)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('GO_0048771', 'tissue remodeling', 36, 'tissue modelling'), ('UBERON_0000479', 'tissue', 36, 'tissue'), ('GO_0006281', 'DNA repair', 57, 'repair'), ('UBERON_0002048', 'lung', 71, 'lungs'), ('UBERON_0000104', 'life cycle', 88, 'life'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0002048', 'lung', 156, 'lung')]
S580-PMC4113768	PMC4113768	7/2014	S580-PMC4113768	['AIM: the PRESENT STUDY EXAMINED IF exposure to Vitamin D from fortified Margarine and milk during Prenatal Life INFLUENCED Birth weight.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 112)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_6784', 'mestranol', 72, 'margarine'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('UBERON_0000104', 'life cycle', 107, 'life'), ('GO_0007567', 'parturition', 123, 'birth')]
S582-PMC4113768	PMC4113768	7/2014	S582-PMC4113768	['the INFLUENCE of Vitamin D exposure during Prenatal Life on Birth weight was INVESTIGATED among 59,411 danish children by comparing Birth weight among Individuals Born before, during, and after fortification.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 77)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('GO_0007567', 'parturition', 60, 'birth'), ('GO_0007567', 'parturition', 132, 'birth'), ('NCBITaxon_1', 'root', 151, 'individuals'), ('GO_0007567', 'parturition', 163, 'born')]
S587-PMC4113768	PMC4113768	7/2014	S587-PMC4113768	['conclusion: exposure to Vitamin D from fortified Margarine and milk during Prenatal Life altered Birth weight, but the ASSOCIATIONS were INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_6784', 'mestranol', 49, 'margarine'), ('GO_0007565', 'female pregnancy', 75, 'prenatal'), ('UBERON_0000104', 'life cycle', 84, 'life'), ('GO_0007567', 'parturition', 97, 'birth')]
S782-PMC4113768	PMC4113768	7/2014	S782-PMC4113768	['RANDOMIZED controlled trials of Vitamin D supplementation MAY BE WARRANTED for infants with low 25(Oh)D during the initial months of Life, BUT careful selection of the regimen with close monitoring of safety for those who reach high 25(Oh)D levels will be NECESSARY.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 58), ('FUTURE_WORK', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('IMPORTANT_CONSIDERATION', 256)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('UBERON_0000104', 'life cycle', 133, 'life'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
S1345-PMC4113768	PMC4113768	7/2014	S1345-PMC4113768	['it is our IMPRESSION that quality of Life in MOST cancer patients was good after Vitamin D supplementation, and in those who died this was right up until their final stage.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('PROBABLE_UNDERSTANDING', 45)]	2	[('UBERON_0000104', 'life cycle', 37, 'life'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
S1347-PMC4113768	PMC4113768	7/2014	S1347-PMC4113768	['cancer patients APPEAR to have an improved quality of Life after Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 16)]	1	[('UBERON_0000104', 'life cycle', 54, 'life'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
S1701-PMC4113768	PMC4113768	7/2014	S1701-PMC4113768	['Life Style is a more significant FACTOR that CONTRIBUTES in Vitamin D insufficiency EVEN in a sun rich country like pakistan.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 84)]	3	[('UBERON_0000104', 'life cycle', 0, 'Life'), ('GO_0051320', 'S phase', 5, 'style'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
S1792-PMC4113768	PMC4113768	7/2014	S1792-PMC4113768	['background: within the lina cohort study maternal as well as newborn Vitamin D levels were shown to be positively ASSOCIATED with Allergic Sensitisation and Food Allergy Development within the first two years of Life.']	[('SUPERFICIAL_RELATIONSHIP', 114)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0046631', 'alpha-beta T cell activation', 130, 'allergic sensitisation'), ('CHEBI_33290', 'food', 157, 'food'), ('GO_0048467', 'gynoecium development', 157, 'food allergy development'), ('UBERON_0000104', 'life cycle', 212, 'life')]
S1810-PMC4113768	PMC4113768	7/2014	S1810-PMC4113768	['DUE to pleiotropic Vitamin D EFFECTS it INFLUENCES NOT ONLY physical and mental health status BUT ALSO the quality of Life.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 51), ('ANOMALY_CURIOUS_FINDING', 94)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
S1834-PMC4113768	PMC4113768	7/2014	S1834-PMC4113768	['during this period, the danish government mandated the fortification of Margarine with Vitamin D, 1.25 mg/100 g. in this talk we will analyze and discuss the benefits ASSOCIATED with Prenatal Consumption of Vitamin D fortified Foods in terms of the development of schizophrenia amongst the progeny later in Life.']	[('SUPERFICIAL_RELATIONSHIP', 167)]	1	[('CHEBI_6784', 'mestranol', 72, 'margarine'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'prenatal'), ('GO_0007631', 'feeding behavior', 192, 'consumption'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('CHEBI_33290', 'food', 227, 'foods'), ('UBERON_0000104', 'life cycle', 307, 'life')]
S1841-PMC4113768	PMC4113768	7/2014	S1841-PMC4113768	['TO TEST the HYPOTHESIS of an ASSOCIATION between the Prenatal exposure to Vitamin D fortified Foods and the risk of the progeny developing schizophrenia later in Life, cox regression models were fit.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 29)]	3	[('GO_0007565', 'female pregnancy', 53, 'prenatal'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33290', 'food', 94, 'foods'), ('UBERON_0000104', 'life cycle', 162, 'life')]
S2421-PMC4113768	PMC4113768	7/2014	S2421-PMC4113768	['conclusions: in addition to the mechanistic INSIGHTS afforded by ASSOCIATIONS between maternal free 25(oh)-Vitamin D index, rxra methylation in Umbilical Cord dna, and childhood bmc, such epigenetic marks in early Life MIGHT represent NOVEL BIOMARKERS for adverse bone outcomes in the offspring.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 219), ('FULL_UNKNOWN', 235), ('SUPERFICIAL_RELATIONSHIP', 241)]	5	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 144, 'umbilical cord'), ('UBERON_0000104', 'life cycle', 214, 'life')]
S2593-PMC4113768	PMC4113768	7/2014	S2593-PMC4113768	['THUS, OUR STUDY AIMED TO ASSESS IF Intake of Foods fortified with Vitamin D during Gestation had an EFFECT on the RISK of t1d later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 114)]	7	[('GO_0007631', 'feeding behavior', 35, 'intake'), ('CHEBI_33290', 'food', 45, 'foods'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'gestation'), ('UBERON_0000104', 'life cycle', 135, 'life')]
S138-PMC4171568	PMC4171568	9/2014	S138-PMC4171568	['in a large-scale Birth cohort study of 9,114 people in finland, the use of Vitamin D supplements in the first year of Life was ASSOCIATED with a reduced risk of developing schizophrenia at 31\xa0years of age, with higher doses SEEN as more beneficial than lower amounts [110].']	[('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 224)]	2	[('GO_0007567', 'parturition', 17, 'birth'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
S14-PMC4256222	PMC4256222	12/2014	S14-PMC4256222	['introduction\nAdult bone mass MAY BE INFLUENCED by FACTORS operating as early as in fetal Life[1], and there has in particular been interest on the ROLE of maternal Vitamin D status in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('UBERON_0007023', 'adult organism', 13, 'Adult'), ('UBERON_0000104', 'life cycle', 89, 'life'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
S16-PMC4256222	PMC4256222	12/2014	S16-PMC4256222	['CONSEQUENTLY, offspring of mothers with low status of Vitamin D MAY BE in a deficient state already from the first days of Life.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 64)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0000104', 'life cycle', 123, 'life')]
S25-PMC4256222	PMC4256222	12/2014	S25-PMC4256222	['in a prospective cohort with follow up over two decades, we therefore EXAMINED WHETHER the risk of bone fractures during the first 18 years of Life was ASSOCIATED with the maternal status of Vitamin D in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('UBERON_0000104', 'life cycle', 143, 'life'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
S103-PMC4256222	PMC4256222	12/2014	S103-PMC4256222	['HOWEVER, IF our results are reliable, there MIGHT be OTHER aspects UNDERLYING a seasonal variation during Pregnancy on bone fracture risk later in Life INDEPENDENTLY of Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
S1-PMC4263713	PMC4263713	12/2014	S1-PMC4263713	['our PREVIOUS STUDY DEMONSTRATED that Gestational or early-Life Vitamin A deficiency decreases the number of Immune Cells in offspring.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 19)]	2	[('GO_0007565', 'female pregnancy', 37, 'gestational'), ('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin A'), ('CL_0000738', 'leukocyte', 108, 'immune cells'), ('UBERON_0002405', 'immune system', 108, 'immune')]
S185-PMC4277121	PMC4277121	12/2015	S185-PMC4277121	['antioxidants\noxidative stress and Mitochondrial dysfunction are both CONSIDERED hallmarks of ds Tissues and CONTRIBUTORS to Neurological phenotypes across the ds Lifespan.1,91cortical Neurons derived from ds fetal Brains show elevated levels of Reactive Oxygen Species, and survival is enhanced by treatment with Antioxidants.92several Hsa21 Genes, among them Sod1 , Bach1 , ets2 , and S100B , are KNOWN to CONTRIBUTE to the Regulation of oxidative stress when Overexpressed.9CONSISTENT with these OBSERVATIONS, it was SHOWN that levels of oxidative stress are elevated in the Brains of Adult ts65dn, and when male ts65dn Mice were Fed a diet high in Vitamin E (0.4 g per kg) from the age of 4 months to ~8 months and 10 months, the levels of oxidative stress were decreased.93performance in the Wram was improved at 8 months, and at 10 months; loss of the Trka receptor in the Bfcn had been PREVENTED.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 398), ('SUPERFICIAL_RELATIONSHIP', 407), ('SUPERFICIAL_RELATIONSHIP', 425), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 519), ('SUPERFICIAL_RELATIONSHIP', 892)]	11	[('GO_0005739', 'mitochondrion', 34, 'mitochondrial'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0001016', 'nervous system', 124, 'neurological'), ('UBERON_0000104', 'life cycle', 162, 'lifespan'), ('CL_0000540', 'neuron', 184, 'neurons'), ('UBERON_0000955', 'brain', 214, 'brains'), ('CHEBI_26523', 'reactive oxygen species', 245, 'reactive oxygen species'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 313, 'antioxidants'), ('PR_000008820', 'heat shock protein beta-8', 336, 'Hsa21'), ('SO_0000704', 'gene', 342, 'genes'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 360, 'SOD1'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 367, 'BACH1'), ('PR_000014404', 'protein S100-A11', 386, 'S100B'), ('GO_0065007', 'biological regulation', 425, 'regulation'), ('GO_0003054', 'circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus', 461, 'overexpressed'), ('UBERON_0000955', 'brain', 577, 'brains'), ('UBERON_0007023', 'adult organism', 587, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 622, 'mice'), ('GO_0007631', 'feeding behavior', 632, 'fed'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 796, 'WRAM'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 857, 'TRKA'), ('UBERON_0001943', 'midbrain tegmentum', 878, 'BFCN')]
S133-PMC4303849	PMC4303849	1/2015	S133-PMC4303849	['25Ohd values lesser than 50 nmol/l MAY sustain long-term adverse health consequences and are classified as “deficiency.” the 75 nmol/l cut-off is the point above which there is no upper stimulation of pth [102] and was thereafter designated as “sufficient.” HOWEVER, heaney POINTED out that 25Ohd concentrations < 80 nmol/l are ASSOCIATED with reduced calcium absorption and osteoporosis risk [103]; therefore, values lesser than 75 nmol/l are considered AS “insufficient.” the conversion factor between 25Ohd nmol/l and ng/ml is 2.5 (table 2).nutrients-07-00443-t001_table 1\n\ncaption (table-wrap): table 1\n\ntargets Modulated by Calcitriol in the Human Placenta (+ = stimulation; − = inhibition).targetbiological networkregulationbioeffectcell typereferenceplacental Lactogencell Life and death+growth controltrophoblast[97]Tnf-Αimmune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Il-6Immune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Csf2 (Colony Stimulating Factor 2)immune function−immunosupressiondecidual Cells[89]hctdimmune function+restraining infectiontrophoblast[90]Decidual Cells[89]Cyp24A1Bone and Mineral Metabolism+Calcitriol Catabolismtrophoblast[12]Decidual Cells[104]Cyp27B1Bone and Mineral Metabolism−Calcitriol synthesistrophoblast[12]Il-10 (Interleukin 10)immune function−reducing risk of infectiontrophoblast[105]Kcnh1 (potassium voltage-Gated channel)Cell Life and Death−unknowntrophoblast[106]Calbindin-D 28 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61,62]Calbindin-D 9 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61]hcg (Human Chorionic Gonadotrophin)Cell Life and Death+, −maintenance of Pregnancytrophoblast[96]3β-hsd (3Β-Hydroxysteroid dehydrogenase) *Cell Life and Death+Progesterone Synthesistrophoblast[95]Cyp19 (aromatase) *Cell Life and Death+Estradiol Synthesistrophoblast[95]Prolactincell Life and Death+Establishment Of Pregnancydecidual Cells[107]Vdrbone and Mineral Metabolism+allowing Calcitriol actionstrophoblast[62]Platelet-Activating factor acetylhydrolasecell life and Death−inactivation of Platelet-Activating factordecidual Macrophages[108]Hoxa10 (Homeobox A10)Cell Life and Death+Embryo Implantationdecidual cells[109]Osteopontinbone and Mineral Metabolism+Embryo Implantationdecidual Cells[104]Hbd2Immune function+restraining infectiontrophoblast[93]Hbd3Immune function+restraining infectiontrophoblast[93]\n* only observed at the enzyme activity level.nutrients-07-00443-t002_table 2\n\ncaption (table-wrap): table 2\n\ncut-offs in Vitamin D status according to the Endocrine society [110].Vitamin D status25ohd (nmol/l)25Ohd (ng/ml)severe deficiency<25<10deficiency<50<20insufficiency<75<30sufficiency75–11030–44toxicity>250>100\ntable 2shows the criteria for vd status as PROPOSED by the Endocrine society.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 258), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBABLE_UNDERSTANDING', 455), ('INCOMPLETE_EVIDENCE', 2831)]	6	"[('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 0, '25OHD'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 291, '25OHD'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 504, '25OHD'), ('GO_0065007', 'biological regulation', 616, 'modulated'), ('CHEBI_17823', 'calcitriol', 629, 'calcitriol'), ('NCBITaxon_9606', 'Homo sapiens', 647, 'human'), ('UBERON_0001987', 'placenta', 653, 'placenta'), ('CHEBI_35417', 'alpha-amino-acid residue radical', 767, 'lactogenCell'), ('PR_000009797', 'LIM/homeobox protein Lhx9', 767, 'lactogenCell'), ('UBERON_0000104', 'life cycle', 780, 'life'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 824, 'TNF-αImmune'), ('PR_000008988', 'interleukin-1 family member 5', 922, 'IL-6Immune'), ('PR_000005890', 'crooked neck-like protein 1', 1019, 'CSF2'), ('PR_000005528', 'chloride channel protein, skeletal muscle', 1025, 'colony stimulating factor 2'), ('CL_0000573', 'retinal cone cell', 1094, 'cells'), ('CL_0000635', ""Deiter's cell"", 1159, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1177, 'CYP24A1Bone'), ('CHEBI_46662', 'mineral', 1193, 'mineral'), ('GO_0008152', 'metabolic process', 1201, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1212, 'Calcitriol'), ('GO_0019065', 'receptor-mediated endocytosis of virus by host cell', 1212, 'Calcitriol catabolismTrophoblast'), ('CL_0000635', ""Deiter's cell"", 1248, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1267, 'CYP27B1Bone'), ('CHEBI_46662', 'mineral', 1283, 'mineral'), ('GO_0008152', 'metabolic process', 1291, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1302, 'Calcitriol'), ('PR_000001470', 'interleukin-28B', 1337, 'IL-10'), ('PR_000001470', 'interleukin-28B', 1344, 'Interleukin 10'), ('PR_000000793', 'voltage-gated potassium channel KCNH4', 1417, 'KCNH1'), ('PR_000004587', 'beta-1,3-galactosyltransferase 6', 1441, '-gated'), ('GO_0008219', 'cell death', 1456, 'Cell life ... death'), ('PR_000004968', 'calretinin', 1499, 'Calbindin-D 28'), ('CHEBI_46662', 'mineral', 1526, 'mineral'), ('GO_0008152', 'metabolic process', 1534, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1545, 'Calcium'), ('PR_000004998', 'calmodulin-regulated spectrin-associated protein 1', 1579, 'Calbindin-D'), ('CHEBI_46662', 'mineral', 1605, 'mineral'), ('GO_0008152', 'metabolic process', 1613, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1624, 'Calcium'), ('NCBITaxon_9606', 'Homo sapiens', 1660, 'human'), ('PR_000005170', 'CD37 molecule', 1666, 'chorionic gonadotrophin'), ('UBERON_0003124', 'chorion', 1666, 'chorionic'), ('GO_0008219', 'cell death', 1690, 'Cell life ... death'), ('GO_0006412', 'translation', 1728, 'pregnancyTrophoblast'), ('CHEBI_36864', '25-hydroxy steroid', 1760, '3β-hydroxysteroid'), ('GO_0008219', 'cell death', 1794, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1799, 'life'), ('CHEBI_17026', 'progesterone', 1814, 'Progesterone'), ('GO_0072598', 'protein localization to chloroplast', 1814, 'Progesterone synthesisTrophoblast'), ('PR_000006100', 'aromatase', 1851, 'CYP19'), ('GO_0008219', 'cell death', 1870, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1875, 'life'), ('CHEBI_4856', 'esmolol', 1890, 'Estradiol'), ('GO_0072596', 'establishment of protein localization to chloroplast', 1890, 'Estradiol synthesisTrophoblast'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 1924, 'ProlactinCell'), ('GO_0006266', 'DNA ligation', 1938, 'life ... death'), ('GO_0006884', 'cell volume homeostasis', 1953, 'Establishment of pregnancyDecidual cells'), ('CL_0000573', 'retinal cone cell', 1988, 'cells'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1998, 'VDRBone'), ('CHEBI_46662', 'mineral', 2010, 'mineral'), ('GO_0008152', 'metabolic process', 2018, 'metabolism'), ('CHEBI_17823', 'calcitriol', 2038, 'calcitriol'), ('CL_0000233', 'platelet', 2071, 'Platelet'), ('GO_0030168', 'platelet activation', 2071, 'Platelet-activating'), ('GO_0007608', 'sensory perception of smell', 2127, '... death'), ('CL_0000233', 'platelet', 2149, 'platelet'), ('GO_0030168', 'platelet activation', 2149, 'platelet-activating'), ('CL_0000235', 'macrophage', 2184, 'macrophages'), ('PR_000008689', 'homeobox protein Hox-A13', 2200, 'HOXA10'), ('PR_000008469', 'holocytochrome c-type synthase', 2208, 'Homeobox A10'), ('GO_0008219', 'cell death', 2221, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 2226, 'life'), ('GO_0007601', 'visual perception', 2241, 'Embryo'), ('UBERON_0000922', 'embryo', 2241, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2248, 'implantationDecidual'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 2279, 'OsteopontinBone'), ('CHEBI_46662', 'mineral', 2299, 'mineral'), ('GO_0008152', 'metabolic process', 2307, 'metabolism'), ('UBERON_0000922', 'embryo', 2318, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2325, 'implantationDecidual'), ('CL_0000573', 'retinal cone cell', 2346, 'cells'), ('PR_000000035', 'BMP receptor type-1A', 2356, 'HBD2Immune'), ('PR_000000035', 'BMP receptor type-1A', 2412, 'HBD3Immune'), ('CHEBI_27300', 'vitamin D', 2590, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 2624, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 2648, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2648, 'Vitamin'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 2678, '25OHD'), ('UBERON_0005063', 'left ventricular compact myocardium', 2847, 'Endocrine')]"
S1-PMC4329404	PMC4329404	10/2014	S1-PMC4329404	['we INVESTIGATED the EFFECT of early-Life Vitamin D deficiency on the development of Murine neonatal allergic Airways disease (aad).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('UBERON_0000104', 'life cycle', 36, 'life'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('NCBITaxon_39107', 'Murinae', 84, 'murine'), ('UBERON_0001005', 'respiratory airway', 109, 'airways')]
S17-PMC4329404	PMC4329404	10/2014	S17-PMC4329404	['CONVERSELY, increased asthma was REPORTED in Adulthood after a period of Vitamin D supplementation during the first year of Life (10).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 33)]	2	[('UBERON_0000113', 'post-juvenile adult stage', 45, 'adulthood'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life')]
S32-PMC4329404	PMC4329404	10/2014	S32-PMC4329404	['we HYPOTHESIZED that pups experiencing in utero and early-Life Vitamin D deficiency would develop more SEVERE hdm-induced Airway hyper-responsiveness (ahr), Eosinophilic inflammation and remodelling due to a reduction in Regulatory T Cells in the Lung.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 103)]	2	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 122, 'airway'), ('CL_0000771', 'eosinophil', 157, 'eosinophilic'), ('CL_0000815', 'regulatory T cell', 221, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 221, 'regulatory'), ('UBERON_0002048', 'lung', 247, 'lung')]
S78-PMC4329404	PMC4329404	10/2014	S78-PMC4329404	['caption (fig): figure 2\n\nintroduction of dietary Vitamin D after in utero and early-Life insufficiency CAN reduce Eosinophilic Lung inflammation.']	[('INCOMPLETE_EVIDENCE', 103)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 84, 'life'), ('CL_0000771', 'eosinophil', 114, 'eosinophilic'), ('UBERON_0002048', 'lung', 127, 'lung')]
S87-PMC4329404	PMC4329404	10/2014	S87-PMC4329404	['Vitamin D insufficiency in utero and in early Life promotes Pulmonary th2 skewing and reduced Il-10+T Regulatory Cells\nto DETERMINE the ROLE of Vitamin D in T-Cell Differentiation, we analysed Th2 Cells and Il-10+T Regulatory Cells in the Lungs of pups.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 122), ('SUPERFICIAL_RELATIONSHIP', 136)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 46, 'life'), ('UBERON_0002048', 'lung', 60, 'pulmonary'), ('PR_000001470', 'interleukin-28B', 94, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 100, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 102, 'regulatory'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CL_0000084', 'T cell', 157, 'T-cell'), ('GO_0030217', 'T cell differentiation', 157, 'T-cell differentiation'), ('CL_0000546', 'T-helper 2 cell', 193, 'Th2 cells'), ('PR_000001470', 'interleukin-28B', 207, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 213, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 215, 'regulatory'), ('UBERON_0002048', 'lung', 239, 'lungs')]
S90-PMC4329404	PMC4329404	10/2014	S90-PMC4329404	['CONVERSELY, Pulmonary cd3+Cd4+Il-10+T Regulatory Cells were significantly reduced in pups exposed to in utero and early-Life Vitamin D insufficiency (fig.3d).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('UBERON_0002048', 'lung', 12, 'pulmonary'), ('PR_000001204', 'C-C chemokine receptor type 8', 26, 'CD4'), ('PR_000001470', 'interleukin-28B', 30, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 36, 'T regulatory cells'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 36, 'T regulatory'), ('UBERON_0000104', 'life cycle', 120, 'life'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
S102-PMC4329404	PMC4329404	10/2014	S102-PMC4329404	['supplementation with Vitamin D after in utero and early-Life insufficiency reduces Serum Ige in pups at 6\xa0weeks of age, BUT NOT th2 cytokines\nwe measured Serum total and hdm-specific Ige TO ASSESS whether early-Life Vitamin D insufficiency AFFECTED sensitization to Allergen (fig.4a).']	[('ANOMALY_CURIOUS_FINDING', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 240)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000104', 'life cycle', 56, 'life'), ('UBERON_0001977', 'blood serum', 83, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 89, 'IgE'), ('UBERON_0001977', 'blood serum', 154, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 183, 'IgE'), ('UBERON_0000104', 'life cycle', 211, 'life'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('CHEBI_50904', 'allergen', 266, 'allergen')]
S105-PMC4329404	PMC4329404	10/2014	S105-PMC4329404	['caption (fig): figure 4\n\nintroduction of dietary Vitamin D after in utero and early-Life insufficiency CAN reduce Ige in pups at 6\xa0weeks of age.']	[('INCOMPLETE_EVIDENCE', 103)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 84, 'life'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 114, 'IgE')]
S121-PMC4329404	PMC4329404	10/2014	S121-PMC4329404	['HOWEVER, pups that were weaned onto a Vitamin D-replete diet at 3\xa0weeks of age after in utero and early-Life insufficiency had reduced levels of Lung collagen following 6\xa0weeks of Allergen exposure (fig.5b).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000104', 'life cycle', 104, 'life'), ('UBERON_0002048', 'lung', 145, 'lung'), ('CHEBI_50904', 'allergen', 180, 'allergen')]
S140-PMC4329404	PMC4329404	10/2014	S140-PMC4329404	['ours is the FIRST STUDY TO INVESTIGATE the IMPACT of maternal Vitamin D status on early-Life allergic inflammation.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000104', 'life cycle', 88, 'life')]
S141-PMC4329404	PMC4329404	10/2014	S141-PMC4329404	['a PREVIOUS STUDY has investigated the EFFECT of in utero and early-Life Vitamin D deficiency on aad, BUT Allergen challenge was commenced in Adult Mice, rather than during the Neonatal Period (32).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101)]	3	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_50904', 'allergen', 105, 'allergen'), ('UBERON_0007023', 'adult organism', 141, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mice'), ('UBERON_0007221', 'neonate stage', 176, 'neonatal period')]
S147-PMC4329404	PMC4329404	10/2014	S147-PMC4329404	['this highlights the IMPORTANCE of age and Vitamin D status on Lung function in Adults COMPARED TO in utero and early-Life deficiency.']	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 62, 'lung'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('UBERON_0000104', 'life cycle', 117, 'life')]
S149-PMC4329404	PMC4329404	10/2014	S149-PMC4329404	['overall, GIVEN OUR FINDINGS in a neonatal Mouse MODEL, and PREVIOUS REPORTS of Vitamin D deficiency in utero through Adulthood not resulting in significantly WORSE ahr, it SEEMS LIKELY that in the context of asthma in early Life, Vitamin D deficiency modifies Immunological Responses To Allergen by the induction of an exaggerated th2 skewed response and eosinophilia.']	[('INCOMPLETE_EVIDENCE', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 158), ('ANOMALY_CURIOUS_FINDING', 172), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 178)]	10	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mouse'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 117, 'adulthood'), ('UBERON_0000104', 'life cycle', 224, 'life'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 260, 'immunological responses to allergen'), ('CHEBI_50904', 'allergen', 287, 'allergen')]
S184-PMC4329404	PMC4329404	10/2014	S184-PMC4329404	['our data SUGGEST Vitamin D deficiency in utero and early Life CONTRIBUTES to worse Eosinophilic inflammation and that Vitamin D supplementation after weaning reduces the development of both Pulmonary Eosinophilia and remodelling.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0000104', 'life cycle', 57, 'life'), ('CL_0000771', 'eosinophil', 83, 'eosinophilic'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002048', 'lung', 190, 'pulmonary'), ('CL_0000771', 'eosinophil', 200, 'eosinophilia')]
S185-PMC4329404	PMC4329404	10/2014	S185-PMC4329404	['THEREFORE, ALTHOUGH it does not SEEM LIKELY that Vitamin D deficiency per se causes asthma in early Life, it is LIKELY that Vitamin D deficiency CONTRIBUTES to increased disease severity in children with asthma and that supplementation MAY reduce severity.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 11), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 236)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
S70-PMC4329745	PMC4329745	10/2014	S70-PMC4329745	['as well, the RELATIONSHIP between schizophrenia in Adult men and Vitamin D supply during the first year of Life was SHOWN in a study conducted by mcgrath et al.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 116)]	2	[('UBERON_0007023', 'adult organism', 51, 'adult'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000104', 'life cycle', 107, 'life')]
S94-PMC4340999	PMC4340999	3/2015	S94-PMC4340999	['for latitudes with distinct seasonal changes in availability of uvb, there is a WELL-DOCUMENTED seasonal cycle in Vitamin D status, with a maximum in late summer and a minimum in late winter.32low Vitamin D during Gestation MAY STRONGLY INFLUENCE susceptibility to obesity later in Life.33\nhowever, relatively LITTLE IS KNOWN about the critical period of fetal growth at which low Vitamin D is of particular IMPORTANCE.']	[('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 224), ('PROBABLE_UNDERSTANDING', 228), ('SUPERFICIAL_RELATIONSHIP', 237), ('FULL_UNKNOWN', 310), ('IMPORTANT_CONSIDERATION', 408)]	7	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestation'), ('UBERON_0000104', 'life cycle', 282, 'life'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
S112-PMC4340999	PMC4340999	3/2015	S112-PMC4340999	['ALTHOUGH THE CURRENT STUDY is UNABLE TO precisely determine the REASON for mob variation in Adult measures of ll, general adiposity, and central adiposity, the study improves our current understanding of a POTENTIAL ASSOCIATION of Prenatal low exposure to Vitamin D during late second and early third trimesters with short ll and adiposity in later Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('DIFFICULT_TASK', 30), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('UBERON_0007023', 'adult organism', 92, 'adult'), ('GO_0007565', 'female pregnancy', 231, 'prenatal'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0000104', 'life cycle', 349, 'life')]
S113-PMC4340999	PMC4340999	3/2015	S113-PMC4340999	['Vitamin D insufficiency during Pregnancy is highly PREVALENT in a diverse range of populations living at various latitudes and in both developed and developing societies.29,33the adverse EFFECTS of Vitamin D insufficiency on offspring during development and later in Life HAVE also BEEN extended greatly.29–31from a PUBLIC HEALTH perspective, the POTENTIAL to PREVENT common chronic diseases via low-cost, simple, and SAFE Food fortification is an attractive option.33\nsome POTENTIAL limitations of this study WARRANT CONSIDERATION.']	[('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 272), ('IMPORTANT_CONSIDERATION', 316), ('INCOMPLETE_EVIDENCE', 347), ('SUPERFICIAL_RELATIONSHIP', 360), ('IMPORTANT_CONSIDERATION', 418), ('INCOMPLETE_EVIDENCE', 474), ('FUTURE_WORK', 510), ('FUTURE_WORK', 518)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000104', 'life cycle', 267, 'life'), ('CHEBI_33290', 'food', 423, 'food')]
S125-PMC4340999	PMC4340999	3/2015	S125-PMC4340999	['this is also the FIRST-ever population-BASED EVIDENCE LINKING low Prenatal sun-RELATED uvb exposure (and lower Vitamin D by PROXY) to ll and the susceptibility to obesity later in Life and also SUGGESTING that late second and early third trimesters MIGHT be a CRITICAL period for the above-mentioned EFFECTS ALTHOUGH such EVIDENCE is non-specific, it WARRANTS FURTHER STUDIES in this AREA.']	[('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 249), ('IMPORTANT_CONSIDERATION', 260), ('SUPERFICIAL_RELATIONSHIP', 300), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('INCOMPLETE_EVIDENCE', 322), ('FUTURE_WORK', 351), ('FUTURE_WORK', 360), ('FUTURE_WORK', 384)]	15	[('GO_0007565', 'female pregnancy', 66, 'prenatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
S61-PMC4417995	PMC4417995	4/2015	S61-PMC4417995	['[30] OBSERVED that higher intake of Vitamin D during the first year of Life was CORRELATED with increased risk of eczema at age six.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life')]
S7-PMC4452099	PMC4452099	6/2015	S7-PMC4452099	['in conclusion, we FOUND NO EVIDENCE TO SUPPORT that exposure to low dose Vitamin D from the danish mandatory Margarine fortification regimen during Gestational and first Postnatal year of Life changed the risk of developing t1d before the age of 15 years.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 24)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_6784', 'mestranol', 109, 'margarine'), ('GO_0007565', 'female pregnancy', 148, 'gestational'), ('GO_0007567', 'parturition', 170, 'postnatal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
S14-PMC4452099	PMC4452099	6/2015	S14-PMC4452099	['there are several REASONS to SUGGEST that Vitamin D supplementation early in Life MAY CONTRIBUTE to PREVENTING t1d.']	[('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0000104', 'life cycle', 77, 'life')]
S28-PMC4452099	PMC4452099	6/2015	S28-PMC4452099	['the AIM of THIS STUDY was TO ASSESS WHETHER Gestational and early Infancy exposure to small extra doses of Vitamin D coming from fortified Margarine INFLUENCED the risk of developing t1d later in Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 149)]	5	[('GO_0007565', 'female pregnancy', 44, 'gestational'), ('UBERON_0000023', 'wing', 66, 'infancy'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_6784', 'mestranol', 139, 'margarine'), ('UBERON_0000104', 'life cycle', 196, 'life')]
S29-PMC4452099	PMC4452099	6/2015	S29-PMC4452099	['we HYPOTHESISED that t1d risk will be lower among Individuals Born in denmark during the period of obligatory Margarine fortification—and THEREFORE exposed to Vitamin D fortified Food during Gestation or Infancy—compared to Individuals Born in years when Margarine was not fortified—and CONSEQUENTLY unexposed to extra Vitamin D coming from fortified Margarine at any period of early Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 138), ('PROBABLE_UNDERSTANDING', 287)]	3	[('NCBITaxon_1', 'root', 50, 'individuals'), ('GO_0007567', 'parturition', 62, 'born'), ('CHEBI_6784', 'mestranol', 110, 'margarine'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_33290', 'food', 179, 'food'), ('GO_0007565', 'female pregnancy', 191, 'gestation'), ('UBERON_0000023', 'wing', 204, 'infancy'), ('NCBITaxon_1', 'root', 224, 'individuals'), ('GO_0007567', 'parturition', 236, 'born'), ('CHEBI_6784', 'mestranol', 255, 'margarine'), ('CHEBI_27300', 'vitamin D', 319, 'vitamin D'), ('CHEBI_6784', 'mestranol', 351, 'margarine'), ('UBERON_0000104', 'life cycle', 384, 'life')]
S84-PMC4452099	PMC4452099	6/2015	S84-PMC4452099	['one REASON for the absence of a detectable RELATIONSHIP between td risk and Early Life exposure to fortified Margarine COULD BE the actual dose of Vitamin D added to Margarine, and therefore the dose which Individuals were exposed to during Gestation and/or during the first year of Life.']	[('PROBABLE_UNDERSTANDING', 4), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 119)]	3	[('UBERON_0001847', 'lobule of pinna', 76, 'early life'), ('CHEBI_6784', 'mestranol', 109, 'margarine'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_6784', 'mestranol', 166, 'margarine'), ('NCBITaxon_1', 'root', 206, 'individuals'), ('GO_0007565', 'female pregnancy', 241, 'gestation'), ('UBERON_0000104', 'life cycle', 283, 'life')]
S92-PMC4452099	PMC4452099	6/2015	S92-PMC4452099	['AS the maternal Vitamin D fortification had EFFECT on babies´ Vitamin D levels via Breast feeding, Vitamin D intake during the first year of Life was LIKELY to HAVE BEEN lower than the maternal Intake.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 150), ('INCOMPLETE_EVIDENCE', 160)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000310', 'breast', 83, 'breast'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0000104', 'life cycle', 141, 'life'), ('GO_0007631', 'feeding behavior', 194, 'intake')]
S109-PMC4452099	PMC4452099	6/2015	S109-PMC4452099	['conclusions\nwe did not find that Gestational or early Infancy exposure to small extra doses of Vitamin D coming from the danish mandatory Margarine fortification programme INFLUENCED the risk of developing t1d later in Life.']	[('SUPERFICIAL_RELATIONSHIP', 172)]	1	[('GO_0007565', 'female pregnancy', 33, 'gestational'), ('UBERON_0000023', 'wing', 54, 'infancy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_6784', 'mestranol', 138, 'margarine'), ('UBERON_0000104', 'life cycle', 219, 'life')]
S16-PMC4466139	PMC4466139	6/2015	S16-PMC4466139	['Vitamin D levels during fetal Life and the Neonatal Period MAY play a ROLE in the development of these conditions through epigenetic changes [11], THEREFORE, Vitamin D status during Pregnancy and in the newborn COULD provide IMPORTANT information.']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 147), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 225)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 30, 'life'), ('UBERON_0007221', 'neonate stage', 43, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy')]
S2-PMC4595656	PMC4595656	10/2015	S2-PMC4595656	['a NUMBER OF STUDIES to date have investigated the EFFECTS of early-Life Vitamin D deprivation on Adult hippocampus in Animals and Humans, and there is a growing BODY OF EVIDENCE to SUGGEST a ROLE for this hormone in the development of selected hippocampal functions such as latent inhibition and hole board Habituation in Rats.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 191)]	5	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0007023', 'adult organism', 97, 'adult'), ('NCBITaxon_33208', 'Metazoa', 118, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 130, 'humans'), ('GO_0046959', 'habituation', 307, 'habituation'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 322, 'rats')]
S32-PMC4595656	PMC4595656	10/2015	S32-PMC4595656	['in addition, transient deprivation of Vitamin D early in Life leads to changes in the new-born Rat Brain which MAY persist into Adulthood.']	[('INCOMPLETE_EVIDENCE', 111)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000104', 'life cycle', 57, 'life'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 95, 'rat'), ('UBERON_0000955', 'brain', 99, 'brain'), ('UBERON_0000113', 'post-juvenile adult stage', 128, 'adulthood')]
S71-PMC4595656	PMC4595656	10/2015	S71-PMC4595656	['several groups of Rats were treated and compared e.g., no depletion, replete at Birth, replete at weaning, depleted until 10 weeks of age, or depleted between 5 and 10 weeks of age, and they FOUND that ONLY the combined Prenatal and chronic Postnatal Vitamin D deprivation, BUT NOT early Life hypovitaminosis on its own, resulted in an impaired response.']	[('INCOMPLETE_EVIDENCE', 191), ('ANOMALY_CURIOUS_FINDING', 202), ('ANOMALY_CURIOUS_FINDING', 274)]	3	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 18, 'rats'), ('GO_0007567', 'parturition', 80, 'birth'), ('GO_0007565', 'female pregnancy', 220, 'prenatal'), ('GO_0007567', 'parturition', 241, 'postnatal'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('UBERON_0000104', 'life cycle', 288, 'life')]
S96-PMC4624803	PMC4624803	10/2015	S96-PMC4624803	['from a THEORETICAL POINT OF VIEW, in foetal Life and during early childhood, the immature Brain SHOULD BE more vulnerable to environmental INFLUENCES like Vitamin D deficiency [3,4].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0000955', 'brain', 90, 'brain'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
S185-PMC4627942	PMC4627942	10/2015	S185-PMC4627942	['ALTHOUGH it APPEARED TO BE beneficial in the above-mentioned trial in guinea-bissau, researchers at kintampo hdss in ghana FOUND no positive effect of Vitamin A supplements in combination with vaccines during the first few months of Life (68).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 123)]	3	[('CHEBI_27300', 'vitamin D', 151, 'vitamin A'), ('UBERON_0000104', 'life cycle', 233, 'life')]
S221-PMC4627942	PMC4627942	10/2015	S221-PMC4627942	"[""caption (table-wrap): table 5\n\ntackling malnutrition – prevention EFFORTS: findings from indepth studieshdss siteyearauthorsmain findingsbandim hdss, guinea-bissau2004nielsen et al.during civil war, Vitamin A supplementation for children helped reduce mortality.bandim hdss, guinea-bissau2005nielsen et al.during civil war, supplementary Feeding programme helped reduce mortality in children.filabavi hdss, vietnam2009nga et al.fortification with multiple Micronutrients of biscuits provided in schools reduced risk of anaemia and of iron and zinc deficiencies by 40%.nouna hdss, burkina faso2003müller et al.no significant impact of Zinc supplementation for children on height-for-age, weight-for-age, and weight-for-height scores.kintampo hdss, ghana2007newton et al.no positive EFFECT of Vitamin A supplements in combination with vaccines during the first few months of Life.farafenni hdss, gambia2013van der merwe et al.fish oil supplementation had no effect on growth, Intestinal integrity, morbidity, or cognitive development.kilifi hdss, kenya2010akech et al.use of low-dose hypotonic Fluid resuscitation for children who develop shock AS a result of SEVERE malnutrition has poor outcomes in terms of persistent shock, oliguria, and high case fatality.agincourt hdss, south africa2003deen et al.introduction of who guidelines in two hospitals strengthened the management of malnutrition.kintampo hdss, ghana2006tchum et al.vitamin a supplementation increased Liver reserves of mothers during the Postpartum period, with EFFECTS persisting for at least five months.niakhar hdss, senegal2006ly et al.provision of high energy, Nutrient-dense Food supplements to infants aged between four and seven months contributed to decreased Postpartum weight loss in their mothers.west kiang hdss, gambia2011hawkesworth et al.Nutrient supplementation during Pregnancy had little effect on infants’ risk of cardiovascular disease.west kiang hdss, gambia2009hawkesworth et al.protein-energy supplementation of mothers during Pregnancy had no effect on the Blood pressure of their children in adolescence.west kiang hdss, gambia2009prentice et al.Calcium supplementation for Pregnant mothers had no effect on foetal and infant growth.west kiang hdss, gambia2010jarjou et al.women given Calcium Supplements while Pregnant had lower bone Mineral content, bone area and bone Mineral density at the Hip during the 12-month Lactation period than other women.dikgale hdss, south africa2002nthangeni et al.the majority of People with type 2 diabetes had poor Glycaemic Control and were obese or had high blood pressure and were given poor advice by health educators.africa centre hdss, south africa2002o'donnell et al.agencies working to tackle a flood disaster in bangladesh in 1998 achieved MIXED results in terms of meeting international disaster response standards.""]"	[('FUTURE_WORK', 66), ('SUPERFICIAL_RELATIONSHIP', 781), ('PROBABLE_UNDERSTANDING', 1143), ('IMPORTANT_CONSIDERATION', 1158), ('SUPERFICIAL_RELATIONSHIP', 1527), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2776)]	6	[('CHEBI_27300', 'vitamin D', 199, 'vitamin A'), ('GO_0007631', 'feeding behavior', 338, 'feeding'), ('CHEBI_33839', 'macromolecule', 456, 'micronutrients'), ('CHEBI_33340', 'zinc group element atom', 634, 'zinc'), ('CHEBI_27300', 'vitamin D', 791, 'vitamin A'), ('UBERON_0000104', 'life cycle', 873, 'life'), ('UBERON_0000160', 'intestine', 974, 'intestinal'), ('UBERON_0006314', 'bodily fluid', 1092, 'fluid'), ('UBERON_0002107', 'liver', 1466, 'liver'), ('GO_0007565', 'female pregnancy', 1503, 'postpartum'), ('CHEBI_33284', 'nutrient', 1631, 'nutrient'), ('CHEBI_33290', 'food', 1646, 'food'), ('GO_0007565', 'female pregnancy', 1734, 'postpartum'), ('CHEBI_33284', 'nutrient', 1819, 'Nutrient'), ('GO_0007565', 'female pregnancy', 1851, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2016, 'pregnancy'), ('UBERON_0000178', 'blood', 2047, 'blood'), ('CHEBI_31341', 'calcium dihydroxide', 2137, 'Calcium'), ('GO_0007565', 'female pregnancy', 2165, 'pregnant'), ('CHEBI_22313', 'alkaline earth metal atom', 2276, 'calcium'), ('CHEBI_33341', 'titanium atom', 2284, 'supplements'), ('GO_0007565', 'female pregnancy', 2302, 'pregnant'), ('CHEBI_46662', 'mineral', 2326, 'mineral'), ('CHEBI_46662', 'mineral', 2362, 'mineral'), ('UBERON_0001464', 'hip', 2385, 'hip'), ('GO_0007595', 'lactation', 2409, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 2505, 'people'), ('GO_0051162', 'L-arabitol metabolic process', 2542, 'glycaemic control')]
S4-PMC4684854	PMC4684854	12/2015	S4-PMC4684854	['with INCREASING EVIDENCE POINTING TO fetal origins of SOME later Life disease, securing Vitamin D sufficiency in Pregnancy APPEARS TO BE a simple, SAFE, and cost-EFFECTIVE measure that CAN be incorporated into routine Preconception and Prenatal Care in the offices of primary care clinicians.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 54), ('ANOMALY_CURIOUS_FINDING', 123), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 162), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0000104', 'life cycle', 65, 'life'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0007565', 'female pregnancy', 218, 'preconception'), ('GO_0008283', 'cell proliferation', 236, 'prenatal care')]
S38-PMC4684854	PMC4684854	12/2015	S38-PMC4684854	['with the EMERGING EVIDENCE that Vitamin D acts epigenetically in the Regulation of over 2700 different Genes [36], there HAS BEEN much RECENT RESEARCH exploring the widespread prevalence of Vitamin D deficiency through the continuum of Life, including the Gestational and Neonatal Period.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 135)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 69, 'regulation'), ('SO_0000704', 'gene', 103, 'genes'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0000104', 'life cycle', 236, 'life'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('UBERON_0007221', 'neonate stage', 272, 'neonatal period')]
S109-PMC4684854	PMC4684854	12/2015	S109-PMC4684854	['a spanish study to this end FOUND that mothers who had Gestational Vitamin D levels above 75\u2009nmol/l had offspring with a one-third lower rate of acute Respiratory Tract infections during the first year of Life [76].']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('GO_0007565', 'female pregnancy', 55, 'gestational'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 151, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 205, 'life')]
S141-PMC4684854	PMC4684854	12/2015	S141-PMC4684854	['it is time for maternity health providers to be apprised of the POTENTIAL for improved and enduring health and well-Being ASSOCIATED with inexpensive measures to secure Vitamin D nutritional adequacy during Gestation, the most vulnerable time in the Life Cycle of the developing child.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('GO_0016441', 'posttranscriptional gene silencing', 115, '-being'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 207, 'gestation'), ('UBERON_0000104', 'life cycle', 250, 'life cycle')]
S26-PMC4689556	PMC4689556	12/2015	S26-PMC4689556	['we HYPOTHESIZED that Prenatal Vitamin D supplementation during Pregnancy would reduce a child’s healthcare utilisation during the first three years of Life through improved health status, by using the e-hr to quantify our outcome total healthcare utilisation.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('GO_0007565', 'female pregnancy', 21, 'prenatal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('UBERON_0000104', 'life cycle', 151, 'life')]
S141-PMC4689556	PMC4689556	12/2015	S141-PMC4689556	['discussion\nwe EVALUATED WHETHER two specific dosing regimens of Prenatal Vitamin D supplementation COULD reduce health care utilisation in the first three years of Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 99)]	3	[('GO_0007565', 'female pregnancy', 64, 'prenatal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0000104', 'life cycle', 164, 'life')]
S181-PMC4689556	PMC4689556	12/2015	S181-PMC4689556	['in conclusion we have FOUND NO EVIDENCE that supplementation of a Vitamin D deficient, urban mixed race population with either a single Oral bolus dose of 200,000 iu Cholecalciferol at 27 weeks or 800 iu Ergocalciferol daily from 27 weeks until Delivery had any EFFECT on child healthcare utilization in the first 3 years of Life.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 262)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0000165', 'mouth', 136, 'oral'), ('CHEBI_52550', 'theopalauamide', 166, 'cholecalciferol'), ('CHEBI_4910', 'etomidate', 204, 'ergocalciferol'), ('GO_0007567', 'parturition', 245, 'delivery'), ('UBERON_0000104', 'life cycle', 325, 'life')]
S2-PMC4691762	PMC4691762	12/2015	S2-PMC4691762	['with the AIM of determining the clinical and cost-effectiveness of daily Vitamin D supplementation in breastfed infants from age 6–8\u2005weeks to 12\u2005months of age, we have started a double-blind, randomised, placebo-controlled trial of daily 400\u2005iu Vitamin D supplementation during the first year of Life, vitality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('UBERON_0000104', 'life cycle', 296, 'life')]
S15-PMC4691762	PMC4691762	12/2015	S15-PMC4691762	['introduction\nVitamin D is LIKELY to play a ROLE in early infant Immune health, with EMERGING EVIDENCE that early Life Vitamin D deficiency increases the risk of developing childhood diseases such as Food allergy1lower Respiratory infections (lris)2and eczema.3a marked shift to Vitamin D deficiency in early Life in modern populations MAY BE an underlying driver of the REPORTED rise in allergic diseases including Food allergy and eczema.']	[('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 370)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('UBERON_0000104', 'life cycle', 113, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 199, 'food'), ('UBERON_0001004', 'respiratory system', 218, 'respiratory'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('UBERON_0000104', 'life cycle', 308, 'life'), ('CHEBI_33290', 'food', 415, 'food')]
S17-PMC4691762	PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]
S20-PMC4691762	PMC4691762	12/2015	S20-PMC4691762	['objectives\nwith the ultimate GOAL of developing improved PUBLIC HEALTH GUIDELINES for Vitamin D supplementation of infants, we AIM TO DETERMINE IF Vitamin D supplementation in infants from 6 to 8\u2005weeks of age LEADS to a reduction in the following during the first year of Life:\nchallenge-proven Food allergy\nlower Respiratory infections\nFood sensitisation\ndoctor diagnosed eczema\nvitamin D deficiency\n\nmethods and analysis\n\ndesign\nvitality is a double-blind, randomised, placebo-controlled trial of Vitamin D supplementation during the first year of Life.']	[('IMPORTANT_CONSIDERATION', 29), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 71), ('FUTURE_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('SUPERFICIAL_RELATIONSHIP', 209)]	8	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0000104', 'life cycle', 272, 'life'), ('CHEBI_33290', 'food', 295, 'food'), ('UBERON_0001004', 'respiratory system', 314, 'respiratory'), ('CHEBI_33290', 'food', 337, 'Food'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 388, 'D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('UBERON_0000104', 'life cycle', 550, 'life')]
S106-PMC4691762	PMC4691762	12/2015	S106-PMC4691762	['we will not be monitoring Serum 25(Oh)D for safety reasons nor considering the association between 25(Oh)D and outcome frequency given that 400\u2005Iu HAS BEEN SHOWN to be SAFE in term babies,1926preterm infants27and is the current RECOMMENDED dose in the usa, canada, the uk and europe.18\n\ndiscussion\nthe results of the vitality trial will determine WHETHER Vitamin D supplementation has a ROLE in optimising infant Immune health in the first year of Life, reducing the risk of allergic disease and Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 168), ('FUTURE_WORK', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('SUPERFICIAL_RELATIONSHIP', 387)]	5	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 99, '25(OH)D'), ('CHEBI_17883', 'hydrogen chloride', 144, 'IU'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin D'), ('UBERON_0002405', 'immune system', 413, 'immune'), ('UBERON_0000104', 'life cycle', 448, 'life'), ('UBERON_0001004', 'respiratory system', 496, 'respiratory')]
S119-PMC4691762	PMC4691762	12/2015	S119-PMC4691762	['if FOUND to be both efficacious and cost-effective, Vitamin D infant supplementation would provide a readily available, low harm INTERVENTION that would optimise infant Immune health in the first year of Life and significantly reduce the population BURDEN of allergic disease.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 129), ('IMPORTANT_CONSIDERATION', 249)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune'), ('UBERON_0000104', 'life cycle', 204, 'life')]
S30-PMC4730270	PMC4730270	12/2015	S30-PMC4730270	['risks AFFECTING early-Life bp of offspring examined in these cohorts include smoking, low Vitamin D intake, Gestational hypertension, maternal obesity, short-term breastfeeding, excessive Postnatal weight gain, and undernutrition [10,11,12,13,14,15,16,17,18,19,20].']	[('SUPERFICIAL_RELATIONSHIP', 6)]	1	[('UBERON_0000104', 'life cycle', 22, 'life'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'gestational'), ('GO_0007567', 'parturition', 188, 'postnatal')]
S7-PMC4764019	PMC4764019	1/2016	S7-PMC4764019	['the barker HYPOTHESIS HAS BEEN ELABORATED and evaluated in several reviews,2–4BUT TO THE BEST OF MY KNOWLEDGE, there HAS BEEN NO ATTEMPT to evaluate the HYPOTHESIS specifically for Vitamin D. THUS, what i PROPOSE TO explore in THIS very brief REVIEW is the EVIDENCE RELATING UNRECOGNIZED, Perinatal Vitamin D inadequacy to increased risk of certain chronic diseases later in Life, that is, to ascertain WHETHER any such EFFECTS MIGHT be an instance of the “barker HYPOTHESIS.”\ni deliberately avoid use of labels such as “deficient” or “insufficient” in characterizing Vitamin D status, AS these terms are OFTEN LINKED to specific values for serum 25-Hydroxyvitamin D [25(Oh)D], about which there is considerable CONTROVERSY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 153), ('PROBABLE_UNDERSTANDING', 192), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 266), ('INCOMPLETE_EVIDENCE', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('SUPERFICIAL_RELATIONSHIP', 420), ('INCOMPLETE_EVIDENCE', 428), ('INCOMPLETE_EVIDENCE', 464), ('PROBABLE_UNDERSTANDING', 586), ('PROBABLE_UNDERSTANDING', 605), ('SUPERFICIAL_RELATIONSHIP', 611), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 712)]	25	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('GO_0036268', 'swimming', 289, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 289, 'perinatal'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000104', 'life cycle', 375, 'life'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 647, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 668, '25(OH)D')]
S12-PMC4764019	PMC4764019	1/2016	S12-PMC4764019	['INSTEAD, where i FOCUS HERE is on the nonskeletal CONSEQUENCES both of untreated rickets and of lesser degrees of Vitamin D inadequacy, OFTEN not clinically apparent and occurring at critical periods during maturation, in some instances well before the Life Stages when rickets is typically manifest.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('PROBLEM_COMPLICATION', 50), ('PROBABLE_UNDERSTANDING', 136)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('UBERON_0000104', 'life cycle', 253, 'life stages')]
S17-PMC4764019	PMC4764019	1/2016	S17-PMC4764019	['autoimmune disorders\ntwo SERIOUS Autoimmune diseases HAVE BEEN LINKED to low Vitamin D status in early Life, type 1 diabetes mellitus (dm1) and multiple sclerosis (ms).']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0001442', 'skeleton of manus', 33, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0000104', 'life cycle', 103, 'life')]
S37-PMC4764019	PMC4764019	1/2016	S37-PMC4764019	['schizophrenia\nmcgrath et al9have EVALUATED the ASSOCIATION between Vitamin D status at Birth and the development of schizophrenia later in Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 87, 'birth'), ('UBERON_0000104', 'life cycle', 139, 'life')]
S38-PMC4764019	PMC4764019	1/2016	S38-PMC4764019	['denmark has a long-standing practice of storing Cord Blood samples on all newborns, making it possible to explore ASSOCIATIONS between late-Life–onset diseases and Vitamin D status at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 114)]	1	[('UBERON_0002240', 'spinal cord', 48, 'cord'), ('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0000104', 'life cycle', 140, 'life'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007567', 'parturition', 184, 'birth')]
S67-PMC4764019	PMC4764019	1/2016	S67-PMC4764019	['ARE there RECOGNIZED mechanisms whereby Vitamin D status MAY INFLUENCE late-Life outcomes?']	[('EXPLICIT_QUESTION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('EXPLICIT_QUESTION', 89)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0000104', 'life cycle', 76, 'life')]
S65-PMC4770602	PMC4770602	1/2016	S65-PMC4770602	"[""[8] investigators in ANOTHER cohort STUDY REPORTED that the risk of Preeclampsia in the female offspring's first Pregnancy reduced after regular supplementation with Vitamin D in the first year of Life.""]"	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 42)]	2	[('GO_0007128', 'meiotic prophase I', 68, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('UBERON_0000104', 'life cycle', 197, 'life')]
S24-PMC4785305	PMC4785305	3/2016	S24-PMC4785305	"[""ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially.""]"	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
S25-PMC4800340	PMC4800340	5/2016	S25-PMC4800340	"[""THIS STUDY SUGGESTS that low sunlight and PRESUMABLY suboptimal Vitamin D status at Birth is ASSOCIATED with Food Allergy Development in childhood.30a large scale population-based study in australia SHOWED that infants with low Serum 25-Hydroxyvitamin (Oh) D3Levels (≤50 nmol/l) had almost 12 times and 4 times higher risk of developing Peanut and egg allergies, respectively, in the first year of Life THAN infants with adequate Serum Vitamin D level.31HOWEVER, ANOTHER STUDY conducted in germany DEMONSTRATED that 25(Oh)D3Concentration in Pregnant women's Serum and in Cord Blood were positively ASSOCIATED with increased risk of Food Allergy Development among children in the first 2 years.32a RECENT randomized double-blind controlled TRIAL SHOWED that maternal Vitamin D3Supplementation for 6 weeks during Lactation increased the risk of Food allergy diagnosis by 3.42 times [95% confidence interval (ci)=1.02–11.77] among children of supplementation group compared to control group by 2 years of age.33due to lack OF robustly designed studies, a causal ASSOCIATION between Vitamin D status during Prenatal and Neonatal Period and Food allergy Development In Children remains INCONCLUSIVE.""]"	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 452), ('INCOMPLETE_EVIDENCE', 463), ('INCOMPLETE_EVIDENCE', 498), ('SUPERFICIAL_RELATIONSHIP', 598), ('INCOMPLETE_EVIDENCE', 697), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 745), ('ANOMALY_CURIOUS_FINDING', 1020), ('SUPERFICIAL_RELATIONSHIP', 1059), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1181)]	16	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'birth'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0048467', 'gynoecium development', 109, 'food allergy development'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('CHEBI_60346', 'alpha-Kdo-(2->8)-alpha-Kdo-OAll', 234, '25-hydroxyvitamin (OH) D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'peanut'), ('UBERON_0000104', 'life cycle', 398, 'life'), ('UBERON_0001977', 'blood serum', 430, 'serum'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 516, '25(OH)D3concentration'), ('GO_0007565', 'female pregnancy', 541, 'pregnant'), ('UBERON_0001977', 'blood serum', 558, 'serum'), ('UBERON_0009472', 'axilla', 571, 'cord blood'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0048467', 'gynoecium development', 632, 'food allergy development'), ('CHEBI_52915', 'phosphatediyl group', 766, 'vitamin D3supplementation'), ('GO_0007595', 'lactation', 811, 'lactation'), ('CHEBI_33290', 'food', 843, 'food'), ('CHEBI_27300', 'vitamin D', 1079, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1103, 'prenatal'), ('UBERON_0007221', 'neonate stage', 1116, 'neonatal period'), ('CHEBI_33290', 'food', 1136, 'food'), ('GO_0030163', 'protein catabolic process', 1149, 'development in children')]
S55-PMC4811107	PMC4811107	3/2016	S55-PMC4811107	['maternal atopic status was included because the primary goal of the cohort was to study allergic outcomes in the children and Prenatal and early Life Vitamin D levels have been investigated for their ROLE in allergic disease development [22,24–27].']	[('SUPERFICIAL_RELATIONSHIP', 200)]	1	[('GO_0007565', 'female pregnancy', 126, 'prenatal'), ('UBERON_0000104', 'life cycle', 145, 'life'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
S109-PMC4811107	PMC4811107	3/2016	S109-PMC4811107	"[""NOT ONLY do these studies INDICATE that use of the Prenatal level of 25(Oh)D to represent the child's early Life Vitamin D level is not specific, but also the data SUGGEST that a maternal THRESHOLD exists below which the mother LIMITS her CONTRIBUTION of 25(Oh)D to the fetus.""]"	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 164), ('PROBABLE_UNDERSTANDING', 188), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 75, 'D'), ('UBERON_0000104', 'life cycle', 108, 'life'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 255, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 257, '(OH)D')]
S84-PMC4877864	PMC4877864	6/2015	S84-PMC4877864	['maintaining Vitamin D sufficiency in utero and during early Life, to satisfy the Vitamin D receptor transcriptional activity in the Brain, MAY BE IMPORTANT for Brain Development as well as for maintenance of mental function later in Life [25].']	[('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 146)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0000104', 'life cycle', 60, 'life'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000955', 'brain', 132, 'brain'), ('GO_0007420', 'brain development', 160, 'brain development'), ('UBERON_0000955', 'brain', 160, 'brain'), ('UBERON_0000104', 'life cycle', 233, 'life')]
S85-PMC4889866	PMC4889866	5/2016	S85-PMC4889866	['the results, summarized intable 3, SHOWED no significant association between maternal Vitamin D status and the incidence of infection during the first year of Life.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000104', 'life cycle', 159, 'life')]
S111-PMC4889866	PMC4889866	5/2016	S111-PMC4889866	['HOWEVER, in present analyses, ALBEIT an ASSOCIATION between maternal Vitamin D level and Viral Tlr-Triggered Il-10 Response, there was no effect on the PREVALENCE of infectious diseases during the first 12 months of Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ANOMALY_CURIOUS_FINDING', 30), ('SUPERFICIAL_RELATIONSHIP', 40), ('IMPORTANT_CONSIDERATION', 152)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'viral'), ('GO_0033153', 'T cell receptor V(D)J recombination', 95, 'TLR-triggered ... -10 response'), ('PR_000001470', 'interleukin-28B', 109, 'IL-10'), ('UBERON_0000104', 'life cycle', 216, 'life')]
S132-PMC4889866	PMC4889866	5/2016	S132-PMC4889866	['ALTHOUGH OUR study DID NOT SHOW maternal Vitamin D concentration to have a significant IMPACT on the magnitude or functional capacity of the young infant to defend against infection, we BELIEVE OUR STUDY MAY contribute to a BETTER understanding of the EFFECT of Prenatal Vitamin D status on neonatal Innate Immunity and infectious disease during early Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 252)]	9	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 262, 'prenatal'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0045087', 'innate immune response', 300, 'innate immunity'), ('UBERON_0000104', 'life cycle', 352, 'life')]
S7049-PMC4896250	PMC4896250	4/2016	S7049-PMC4896250	['a496 the EFFECT of Cord Serum 25-Hydroxyvitamin D (25(Oh)D) on the development of atopic dermatitis in first 3 years of Life : cocoa study\n\nhyun-ju cho1, youn ho shin2, eun lee3, young-ho kim3, darae lee3, mi-jin kang4, song-i yang5, kangmo ahn6, kyung won kim7, yoon hee kim7, hye-sung won3, soo hyun kim2, suk-joo choi6, young han kim7, jong kwan jun8, eun-jin kim9, jeom gyu lee9, so-yeon lee5, soo-jong hong1, dongin suh10\n\n1department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea;2cha medical center;3asan medical center;4asan institute for Life science, asan medical center;5hallym university sacred Heart hospital;6samsung medical center;7yonsei university college of medicine;8seoul national university college of medicine;9korea national institute of health;10seoul national university hospital\n\ncorrespondence: hyun-ju cho – department of pediatrics, childhood asthma atopy center, environmental health center, asan medical center, university of ulsan college of medicine, south korea\nbackground: the ASSOCIATION between Serum Vitamin D deficiency at Birth and atopic dermatitis (ad) is UNCERTAIN.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 1115), ('FULL_UNKNOWN', 1201)]	3	"[('UBERON_0000948', 'heart', 19, 'Cord'), ('UBERON_0001977', 'blood serum', 24, 'Serum'), ('CHEBI_27844', ""2',3'-cyclic AMP"", 30, '25-Hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('UBERON_0000104', 'life cycle', 120, 'Life'), ('UBERON_0000104', 'life cycle', 650, 'Life'), ('UBERON_0000948', 'heart', 710, 'Heart'), ('UBERON_0001977', 'blood serum', 1135, 'serum'), ('CHEBI_27300', 'vitamin D', 1141, 'vitamin D'), ('GO_0007567', 'parturition', 1165, 'birth')]"
S1-PMC4934634	PMC4934634	11/2015	S1-PMC4934634	['RECENT RESEARCH has SUGGESTED that Vitamin D MAY exert a broad RANGE of ROLES throughout the Human Life Cycle starting from Reproduction to Adult chronic disease risk.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('SUPERFICIAL_RELATIONSHIP', 72)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 93, 'human'), ('UBERON_0000104', 'life cycle', 99, 'life cycle'), ('GO_0007049', 'cell cycle', 104, 'cycle'), ('GO_0000003', 'reproduction', 124, 'reproduction'), ('UBERON_0007023', 'adult organism', 140, 'adult')]
S6-PMC4934634	PMC4934634	11/2015	S6-PMC4934634	['the EFFECT of Vitamin D supplementation during Pregnancy and early Life on maternal and infant outcomes will be of particular FOCUS in this review.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 126)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('UBERON_0000104', 'life cycle', 67, 'life')]
S25-PMC4934634	PMC4934634	11/2015	S25-PMC4934634	['caption (fig): figure 1\n\nmodifying factors that can AFFECT Vitamin D status throughout the Life Cycle.']	[('SUPERFICIAL_RELATIONSHIP', 52)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0000104', 'life cycle', 91, 'life cycle'), ('GO_0007049', 'cell cycle', 96, 'cycle')]
S176-PMC4934634	PMC4934634	11/2015	S176-PMC4934634	['it HAS BEEN PROPOSED that Vitamin D-induced epigenetic changes during development are INVOLVED in susceptibility to multiple morbidities ranging from allergies to cancer later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0000104', 'life cycle', 179, 'life')]
S177-PMC4934634	PMC4934634	11/2015	S177-PMC4934634	['THUS it COULD BE ARGUED that adequate Maternal-fetal transfer of Vitamin D in utero and early Infancy is IMPORTANT for Life-long optimal health.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 105)]	4	[('GO_0007618', 'mating', 38, 'maternal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000023', 'wing', 94, 'infancy'), ('UBERON_0000104', 'life cycle', 119, 'life')]
S266-PMC4934634	PMC4934634	11/2015	S266-PMC4934634	['as PREVIOUSLY mentioned, short-term studies GENERALLY AGREE with its SAFETY BUT long-term STUDIES ARE NEEDED to address the QUESTION of WHETHER large bolus Vitamin D supplementation during Pregnancy is ASSOCIATED with any adverse health outcomes in the offspring later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 90), ('EXPLICIT_QUESTION', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('EXPLICIT_QUESTION', 136), ('SUPERFICIAL_RELATIONSHIP', 202)]	10	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('UBERON_0000104', 'life cycle', 272, 'life')]
S4-PMC4949006	PMC4949006	7/2016	S4-PMC4949006	['Folic Acid SHOULD BE supplemented prior to Conception and continued through AT LEAST the first 28 days of fetal Life to prevent Neural Tube defects, and Vitamin C SHOULD be given to women who smoke to lower the incidence of asthma and wheezing in the children.']	[('FUTURE_WORK', 11), ('PROBABLE_UNDERSTANDING', 76), ('FUTURE_WORK', 163)]	3	[('CHEBI_30751', 'formic acid', 0, 'Folic acid'), ('GO_0007620', 'copulation', 43, 'conception'), ('UBERON_0000104', 'life cycle', 112, 'life'), ('UBERON_0001049', 'neural tube', 128, 'neural tube'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin C')]
S74-PMC4969253	PMC4969253	8/2016	S74-PMC4969253	['the IDEA that changes in Vitamin A-ra status during fetal Life CAN alter structural and mechanical properties of the Lung in Adult Life HAS BEEN SUGGESTED in few studies.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 145)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 33, 'A'), ('UBERON_0000104', 'life cycle', 58, 'life'), ('UBERON_0002048', 'lung', 117, 'lung'), ('UBERON_0000113', 'post-juvenile adult stage', 125, 'adult life')]
S82-PMC4969253	PMC4969253	8/2016	S82-PMC4969253	['REMARKABLY, IF returned to normal Vitamin A diet later in Gestation and throughout their Postnatal Life, Adult Mice show a markedly thick Airway Sm layer.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A'), ('GO_0007565', 'female pregnancy', 58, 'gestation'), ('GO_0007567', 'parturition', 89, 'postnatal'), ('UBERON_0000104', 'life cycle', 99, 'life'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 111, 'mice'), ('UBERON_0001005', 'respiratory airway', 138, 'airway'), ('UBERON_0001290', 'proximal straight tubule', 145, 'SM')]
S337-PMC4989298	PMC4989298	8/2016	S337-PMC4989298	['in RECENT YEARS a POSSIBLE ROLE in PREVENTION HAS BEEN ATTRIBUTED to Vitamin D. indeed, OBSERVATIONAL and cohort studies have DOCUMENTED the existence of a CORRELATION between vitamin d intake (from dietary sources or supplementation) in Pregnant women and children and the risk of wheezing, asthma or Food allergy later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 156)]	9	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 238, 'pregnant'), ('CHEBI_33290', 'food', 302, 'food'), ('UBERON_0000104', 'life cycle', 324, 'life')]
S357-PMC4989298	PMC4989298	8/2016	S357-PMC4989298	['IS the administration of Vitamin D in doses higher than RECOMMENDED intakes for the first year of Life RECOMMENDED for the prevention of allergic diseases?']	[('EXPLICIT_QUESTION', 0), ('FUTURE_WORK', 56), ('FUTURE_WORK', 103), ('EXPLICIT_QUESTION', 154)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 98, 'life')]
S359-PMC4989298	PMC4989298	8/2016	S359-PMC4989298	['IS the administration of Vitamin D in doses compliant with RECOMMENDED intakes SUGGESTED for the first year of Life RECOMMENDED for the prevention of allergic disease?']	[('EXPLICIT_QUESTION', 0), ('FUTURE_WORK', 59), ('INCOMPLETE_EVIDENCE', 79), ('FUTURE_WORK', 116), ('EXPLICIT_QUESTION', 166)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 111, 'life')]
S319-PMC4990268	PMC4990268	8/2016	S319-PMC4990268	['overall, there is NO CONSISTENT EVIDENCE that Antenatal Vitamin A supplementation improves growth of infants through the first year of Life[101].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 21)]	2	[('GO_0007567', 'parturition', 46, 'antenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin A'), ('UBERON_0000104', 'life cycle', 135, 'life')]
S13-PMC4997421	PMC4997421	8/2016	S13-PMC4997421	['introduction\nvitamin a is an ESSENTIAL Nutrient throughout the Lifecycle; HOWEVER, its INFLUENCE is PARTICULARLY CRITICAL during periods when cells Proliferate rapidly and differentiate, such as during Pregnancy.adequate Vitamin A status in the mother is CRITICAL for fetal growth, Morphogenesis, and maturation of multiple Organ Systems, including the Immune System, Lungs, and Eyes [1,2].']	[('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('SUPERFICIAL_RELATIONSHIP', 87), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 255)]	6	[('CHEBI_33284', 'nutrient', 39, 'nutrient'), ('UBERON_0000104', 'life cycle', 63, 'lifecycle'), ('GO_0008283', 'cell proliferation', 148, 'proliferate'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 282, 'morphogenesis'), ('UBERON_0000467', 'anatomical system', 324, 'organ systems'), ('UBERON_0002405', 'immune system', 353, 'immune system'), ('UBERON_0002048', 'lung', 368, 'lungs'), ('UBERON_0000970', 'eye', 379, 'eyes')]
S94-PMC4997567	PMC4997567	8/2016	S94-PMC4997567	['hollis and wagner (2004) [21] NOTICED that ALTHOUGH Breast Milk is adequate for growth and bone mineralization in the first year of Life, it is lacking adequate concentration of Vitamin D. THEREFORE, Vitamin D supplementation MUST BE NECESSARY for Breast-Fed infants.']	[('ANOMALY_CURIOUS_FINDING', 30), ('ANOMALY_CURIOUS_FINDING', 43), ('PROBABLE_UNDERSTANDING', 189), ('IMPORTANT_CONSIDERATION', 226), ('IMPORTANT_CONSIDERATION', 234)]	5	[('UBERON_0000310', 'breast', 52, 'breast'), ('UBERON_0001913', 'milk', 59, 'milk'), ('UBERON_0000104', 'life cycle', 132, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0000310', 'breast', 248, 'breast'), ('GO_0007631', 'feeding behavior', 255, 'fed')]
S10-PMC4998950	PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
S78-PMC5045784	PMC5045784	10/2016	S78-PMC5045784	['two RECENTLY published large intervention trials of additional Vitamin D supplementation during Pregnancy in the united states32and europe33showed TRENDS but no significant decreases in the incidence of childhood wheezing and asthma in the first 3 years of Life among the offspring.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 147)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('UBERON_0000104', 'life cycle', 257, 'life')]
S37-PMC5064894	PMC5064894	10/2016	S37-PMC5064894	['first, THERE HAVE BEEN NO STUDIES examining the EFFECT of Prenatal Vitamin D supplementation on a primary outcome of laboratory-confirmed Viral Respiratory infections in the first 6\xa0months of Life, a high-risk period for both Vitamin D deficiency and Respiratory Tract infections.']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('NCBITaxon_1', 'root', 138, 'viral'), ('UBERON_0001004', 'respiratory system', 144, 'respiratory'), ('UBERON_0000104', 'life cycle', 192, 'life'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 251, 'respiratory tract')]
S130-PMC5084016	PMC5084016	10/2016	S130-PMC5084016	['low Birth weight, impaired Skeletal Development, and Respiratory infections and allergic diseases in the early years of Life are OFTEN ASSOCIATED with INADEQUATE CONTRIBUTION of Vitamin D from the mother’s diet.']	[('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 151), ('SUPERFICIAL_RELATIONSHIP', 162)]	4	[('GO_0007567', 'parturition', 4, 'birth'), ('GO_0001501', 'skeletal system development', 27, 'skeletal development'), ('UBERON_0004288', 'skeleton', 27, 'skeletal'), ('UBERON_0001004', 'respiratory system', 53, 'respiratory'), ('UBERON_0000104', 'life cycle', 120, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
S137-PMC5084016	PMC5084016	10/2016	S137-PMC5084016	['Breastmilk, IN FACT, contains amounts of Vitamin D (<80 iu/l) that are insufficient for deficit PREVENTION in the first year of Life [63].']	[('ANOMALY_CURIOUS_FINDING', 12), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breastmilk'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0000104', 'life cycle', 128, 'life')]
S118-PMC5129897	PMC5129897	10/2016	S118-PMC5129897	"[""“the CURRENTLY AVAILABLE results INDICATE that Vitamin D supplementation during Pregnancy reduces the RISK of Preterm Birth, low Birth weight, Dental caries of infancy, and neonatal infectious diseases such as Respiratory infections and sepsis.”81furthermore, with UNFOLDING RESEARCH into fetal origins of pediatric and Adult disease, EVIDENCE increasingly INDICATES that Gestational Vitamin D indices MAY determine health in later Life.82for example, an INTERESTING cohort study CORRELATING maternal Vitamin D levels at 18\xa0weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with a higher risk of impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10\xa0years, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20\xa0y.83\na RECENT STUDY CONCLUDED that Vitamin D is reduces exacerbations of asthma.84\n\nall-cause mortality rate\ngarland and colleagues85presented a meta-analysis of 32 prospective observational studies that investigated all-cause mortality rate with respect to 25(Oh)D concentration at time of enrollment.""]"	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 102), ('INCOMPLETE_EVIDENCE', 265), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 402), ('ANOMALY_CURIOUS_FINDING', 455), ('SUPERFICIAL_RELATIONSHIP', 480), ('INCOMPLETE_EVIDENCE', 572), ('SUPERFICIAL_RELATIONSHIP', 620), ('INCOMPLETE_EVIDENCE', 838), ('INCOMPLETE_EVIDENCE', 851)]	13	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'preterm'), ('GO_0007567', 'parturition', 118, 'birth'), ('GO_0007567', 'parturition', 129, 'birth'), ('UBERON_0001091', 'calcareous tooth', 143, 'dental'), ('UBERON_0001004', 'respiratory system', 210, 'respiratory'), ('UBERON_0007023', 'adult organism', 320, 'adult'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('UBERON_0000104', 'life cycle', 432, 'life'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D'), ('GO_0007565', 'female pregnancy', 531, 'pregnancy'), ('GO_0007565', 'female pregnancy', 583, 'gestational'), ('CHEBI_27300', 'vitamin D', 595, 'vitamin D'), ('GO_0030324', 'lung development', 662, 'lung development'), ('UBERON_0002048', 'lung', 662, 'lung'), ('GO_0050905', 'neuromuscular process', 704, 'neurocognitive'), ('GO_0051318', 'G1 phase', 767, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 787, 'adolescence'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1089, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1089, '25(OH ... D')]
S39-PMC5310660	PMC5310660	1/2017	S39-PMC5310660	['this latter plays a significant ROLE, SINCE increased Serum Vitamin D concentration is ASSOCIATED with a decreased risk of multiple sclerosis [10,11], and Vitamin D supplementation during the first year of Life is ASSOCIATED with a significantly decreased risk of type 1 diabetes [12].']	[('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('UBERON_0000104', 'life cycle', 206, 'life')]
S60-PMC5322422	PMC5322422	2/2017	S60-PMC5322422	['early vkdb occurs in the first 24 hours of Life BUT typically ONLY is SEEN in infants whose mothers take Medications that interfere with Vitamin K Metabolism (e.g., Anticoagulants, Anticonvulsants, or Antituberculosis Drugs).']	[('ANOMALY_CURIOUS_FINDING', 48), ('ANOMALY_CURIOUS_FINDING', 62), ('INCOMPLETE_EVIDENCE', 70)]	3	[('UBERON_0000104', 'life cycle', 43, 'life'), ('CHEBI_25441', 'mycothiols', 105, 'medications'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin K'), ('GO_0006565', 'L-serine catabolic process', 145, 'K metabolism'), ('CHEBI_33282', 'antibacterial agent', 165, 'anticoagulants'), ('CHEBI_37540', 'arabinarate(2-)', 181, 'anticonvulsants'), ('CHEBI_48617', '5-(hydroxymethyl)piperidine-2,3,4-triol', 201, 'antituberculosis'), ('CHEBI_23888', 'drug', 218, 'drugs')]
S35-PMC5351212	PMC5351212	3/2017	S35-PMC5351212	['THEREFORE, inflammatory factors produced early in Brain Development EITHER directly, by inducing mia, OR indirectly, by the maternal absence of a potent anti-inflammatory factor such as Vitamin D MAY, REPRESENT a CONVERGENT pathway towards developmental Brain abnormalities and psychiatric conditions later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 201), ('SUPERFICIAL_RELATIONSHIP', 213)]	5	[('GO_0007420', 'brain development', 50, 'brain development'), ('UBERON_0000955', 'brain', 50, 'brain'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('UBERON_0000955', 'brain', 254, 'brain'), ('UBERON_0000104', 'life cycle', 310, 'life')]
S57-PMC5372327	PMC5372327	3/2017	S57-PMC5372327	['ALTHOUGH PRELIMINARY results POINT to IMPORTANCE of early Life exposure, the ROLE of Vitamin D in Cognitive Development during childhood and Adolescence REMAINS LARGELY UNSTUDIED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 38), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 169)]	8	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0050787', 'detoxification of mercury ion', 98, 'cognitive development'), ('GO_0048848', 'neurohypophysis morphogenesis', 141, 'adolescence')]
S131-PMC5385921	PMC5385921	4/2017	S131-PMC5385921	['in FUTURE STUDIES, it will be OF INTEREST to explore the CRITICAL window during which low Vitamin D MAY CONTRIBUTE to asd RISK – it is FEASIBLE that exposure in the first few years of Life MAY also CONTRIBUTE to adverse Brain outcomes.']	[('FUTURE_WORK', 3), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 135), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 198)]	9	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('UBERON_0000104', 'life cycle', 184, 'life'), ('UBERON_0000955', 'brain', 220, 'brain')]
S32-PMC5405075	PMC5405075	4/2017	S32-PMC5405075	['IN THE LIGHT of the POSSIBLE parallel-asthma epidemic, cellular molecular studies along with epidemiological data SUGGEST that Vitamin D deficiency MAY have a programming EFFECT in utero and promote a trajectory to develop asthma in childhood and later in Life (2,37–39).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 171)]	5	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0000104', 'life cycle', 256, 'life')]
S34-PMC5405075	PMC5405075	4/2017	S34-PMC5405075	['maternal Vitamin D status and ASSOCIATIONS with asthma in early Life\nthe PUTATIVE EFFECT of Prenatal exposure to Vitamin D on asthmatic phenotypes in early Life has been initially investigated via observational studies based on either maternal dietary Intake of Vitamin D or 25(Oh)D levels in Venous maternal and/or Cord Blood [reviewed in ref.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 73), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 64, 'Life'), ('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0000104', 'life cycle', 156, 'life'), ('GO_0007631', 'feeding behavior', 252, 'intake'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 275, '25(OH)D'), ('UBERON_0001638', 'vein', 293, 'venous'), ('UBERON_0002240', 'spinal cord', 316, 'cord'), ('UBERON_0000178', 'blood', 321, 'blood')]
S42-PMC5405075	PMC5405075	4/2017	S42-PMC5405075	['INCONSISTENCIES across studies HAVE BEEN ATTRIBUTED to a plethora of FACTORS such as diverse study designs, MISSING significant follow-up, lack OF a clear definition of vitamin d sufficiency in Pregnancy, REMARKABLE fluctuations in populations in different latitudes, Genetic heterogeneity, the diversity of assays employed (69), low repeatability of Serum 25(Oh)D values (37), variety of Vitamin D status DETERMINANTS, multifactorial nature and phenotypical diversity of asthma, as well as imprecision in diagnosing asthma in early Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 69), ('PROBLEM_COMPLICATION', 108), ('ANOMALY_CURIOUS_FINDING', 144), ('ANOMALY_CURIOUS_FINDING', 205), ('SUPERFICIAL_RELATIONSHIP', 406)]	8	[('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('SO_0000704', 'gene', 268, 'genetic'), ('UBERON_0001977', 'blood serum', 351, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 360, 'OH)D'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('UBERON_0000104', 'life cycle', 533, 'life')]
S51-PMC5405075	PMC5405075	4/2017	S51-PMC5405075	['in a RECENT randomized placebo-controlled double-blind trial in new zealand, Vitamin D was administrated in unselected Pregnant women from the 27\u2009weeks of Gestation and subsequently in their infants during the first 6\u2009months of Life (placebo/placebo, 1,000/400\u2009iu, and 2,000/800\u2009iu).']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnant'), ('GO_0007565', 'female pregnancy', 155, 'gestation'), ('UBERON_0000104', 'life cycle', 228, 'life')]
S96-PMC5418719	PMC5418719	5/2017	S96-PMC5418719	['moreover, INADEQUATE Vitamin D levels in Cord Blood are ASSOCIATED with Immune status and the prevalence of SEVERE Respiratory Tract infections in the first year of Life, as well as reduced bone density during childhood [18–20].']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 108)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0009472', 'axilla', 41, 'cord blood'), ('UBERON_0002405', 'immune system', 72, 'immune'), ('UBERON_0000065', 'respiratory tract', 115, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 165, 'life')]
S102-PMC5418719	PMC5418719	5/2017	S102-PMC5418719	['this LACK OF EVIDENCE has resulted in VARYING practices among neonatologists, and CONTROVERSY REMAINS about the thresholds and STRATEGIES for Vitamin D intake of 800\xa0iu among vlbw infants earlier in Life.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 127)]	5	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0000104', 'life cycle', 199, 'life')]
S135-PMC5426325	PMC5426325	4/2017	S135-PMC5426325	['the RELATIONSHIP between Vitamin D status during fetal Life and long-term bone health has not previously been widely examined, and results from earlier observational studies SHOWED EITHER no association or a direct association.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 55, 'life')]
S25-PMC5474873	PMC5474873	6/2017	S25-PMC5474873	['reviewed seven STUDIES on Vitamin D and psychosis and CONCLUDED that Individuals with psychosis showed lower Vitamin D levels than healthy controls (16), and a COMPREHENSIVE meta-analysis of observation studies SUGGESTED a strong RELATIONSHIP between Vitamin D deficiency and schizophrenia (17) Vitamin D HAS BEEN FOUND to Modulate Dopamine Neurotransmission (5), and SEVERAL STUDIES REPORTED an ASSOCIATION between early Life Vitamin D deficiency and later psychotic disorder.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 160), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 305), ('INCOMPLETE_EVIDENCE', 368), ('INCOMPLETE_EVIDENCE', 384), ('SUPERFICIAL_RELATIONSHIP', 396)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 69, 'individuals'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 295, 'Vitamin D'), ('GO_0065007', 'biological regulation', 323, 'modulate'), ('CHEBI_18243', 'dopamine', 332, 'dopamine'), ('GO_0061527', 'dopamine secretion, neurotransmission', 332, 'dopamine neurotransmission'), ('UBERON_0000104', 'life cycle', 422, 'life'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D')]
S138-PMC5474873	PMC5474873	6/2017	S138-PMC5474873	['discussion\nin the nordic countries, as elsewhere, sun exposure is by far the most IMPORTANT source of Vitamin D. in a population-based cohort of over 30,000 women, we FOUND an ASSOCIATION between cumulative measures of sun exposure at ages 10–39\u2009years and positive pes later in Life.']	[('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0000104', 'life cycle', 278, 'life')]
S21-PMC5521778	PMC5521778	7/2017	S21-PMC5521778	['in Humans, fetal Lung Vitamin A stores increase during the third Intrauterine trimester, then level off towards term, and decrease, PRESUMABLY by Retinoid mobilization, in early Postnatal Life [13].']	[('PROBABLE_UNDERSTANDING', 132)]	1	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('UBERON_0002048', 'lung', 17, 'lung'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0022293', 'reproductive gland secretion', 65, 'intrauterine'), ('CHEBI_26537', 'retinoid', 146, 'retinoid'), ('GO_0007567', 'parturition', 178, 'postnatal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
S8-PMC5537904	PMC5537904	7/2017	S8-PMC5537904	['our data CONFIRM the HYPOTHESIS that Vitamin D exposure in early Life is ASSOCIATED with neonatal body size and composition.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0000104', 'life cycle', 65, 'life')]
S25-PMC5537904	PMC5537904	7/2017	S25-PMC5537904	['THUS, the PURPOSE of THIS analysis was TO EXAMINE the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and early Life body composition.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 54)]	5	[('GO_0007565', 'female pregnancy', 75, 'prenatal'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 139, 'life')]
S155-PMC5537904	PMC5537904	7/2017	S155-PMC5537904	['these data underscore the INCREASED RISK for both early Life Vitamin D deficiency and increased adiposity conferred to offspring by women with obesity.']	[('IMPORTANT_CONSIDERATION', 26)]	1	[('UBERON_0000104', 'life cycle', 56, 'life'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
S23-PMC5634602	PMC5634602	10/2017	S23-PMC5634602	['the endocrine society also RECOMMENDS a target level of >75 nmol/l and espghan an EVEN higher target of >80 nmol/l.10.1371/journal.pone.0185950.t001\n\ncaption (table-wrap): table 1\nrecommendations for Vitamin D supplementation.recommending bodypatient agerecommended supplementationrecommended target Serum levelcommentsyear of publication american academy of pediatrics—section of breastfeeding and committee on nutrition healthy infants Birth– 12 months of age400 iu daily>50 nmol/l (targeting bone health)*begin soon after Birth, in the first few days of Life.']	[('FUTURE_WORK', 27), ('ANOMALY_CURIOUS_FINDING', 82)]	2	[('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001977', 'blood serum', 300, 'Serum'), ('GO_0007567', 'parturition', 438, 'birth'), ('GO_0007567', 'parturition', 525, 'birth'), ('UBERON_0000104', 'life cycle', 557, 'life')]
S74-PMC5659607	PMC5659607	10/2017	S74-PMC5659607	['primary end-point\n\nasthma/recurrent wheeze\na total of 218 (29%) children were diagnosed with asthma/recurrent wheeze in the vdaart trial and 104 (18%) in copsac2010during the first 3 years of Life ( table 2 ).10.1371/journal.pone.0186657.t002\n\ncaption (table-wrap): table 2\nend-points in the two trials at age 0–3 years.end-point:copsac2010(581)vdaart (806)asthma/recurrent wheeze18% (104 of 581)29% (218 of 748)eczema25% (143 of 581)23% (172 of 751)lrti24% (139 of 581)33% (266 of 806)specific Ige ≥ 0.35 kua/l: Milk, egg, Cat, Dog8% (39 of 471)39% (212 of 544)median (iqr) total Ige, ku/l4.56 (2.50–8.79)31.5 (11.5–103)\na combined analysis of the calculated odds-ratios from the separate trials SHOWED a significant 26% reduced risk of asthma/recurrent wheeze in the Vitamin D vs. control group: or = 0.74 (95% ci, 0.57 to 0.96), p = 0.02 (fig 2aandtable 3), with no heterogeneity among the trials: i2= 0%, p = 0.89.10.1371/journal.pone.0186657.g002\n\ncaption (fig): fig 2\nforest plots of the combined analyses of asthma/recurrent wheeze in copsac2010and vdaart.']	[('INCOMPLETE_EVIDENCE', 697)]	1	[('UBERON_0000104', 'life cycle', 192, 'life'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 495, 'IgE'), ('UBERON_0001913', 'milk', 513, 'milk'), ('NCBITaxon_33208', 'Metazoa', 524, 'cat'), ('NCBITaxon_33208', 'Metazoa', 529, 'dog8'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 581, 'IgE'), ('CHEBI_27300', 'vitamin D', 769, 'vitamin D')]
S131-PMC5659607	PMC5659607	10/2017	S131-PMC5659607	['INTERPRETATION\nthis combined analysis of our two Vitamin D rcts SHOWED a significant 26% reduced risk of the primary end-point asthma/recurrent wheeze during the first 3 years of Life, which SUGGESTS that the non-significant/borderline significant trial responses OBSERVED in the individual intent-to-treat analyses were PARTLY due to LACK OF power caused by an OVERESTIMATION of the treatment effect, RATHER than lack of an intervention effect.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 321), ('INCOMPLETE_EVIDENCE', 335), ('ANOMALY_CURIOUS_FINDING', 340), ('PROBLEM_COMPLICATION', 362), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 402)]	9	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 179, 'life')]
S141-PMC5659607	PMC5659607	10/2017	S141-PMC5659607	['in addition, AS Human fertility is also INFLUENCED by Vitamin D[29,30], it MAY EVEN be worthwhile to TARGET supplementation before Conception to optimize Implantation of the Fertilized Egg and assure sufficient Vitamin D for Lung and Immune Development from the very beginning of Life.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 75), ('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 101)]	5	[('NCBITaxon_9606', 'Homo sapiens', 16, 'human'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007620', 'copulation', 131, 'conception'), ('GO_0007566', 'embryo implantation', 154, 'implantation'), ('GO_0009566', 'fertilization', 174, 'fertilized'), ('CL_0000025', 'egg cell', 185, 'egg'), ('UBERON_0007379', 'shelled egg', 185, 'egg'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0006266', 'DNA ligation', 225, 'lung ...'), ('UBERON_0002048', 'lung', 225, 'lung'), ('GO_0001822', 'kidney development', 234, 'immune development'), ('UBERON_0002405', 'immune system', 234, 'immune'), ('UBERON_0000104', 'life cycle', 280, 'life')]
S105-PMC5679631	PMC5679631	11/2017	S105-PMC5679631	['600 (reference)0 (reference)quintile 2680.01 (-0.21, 0.24)0.01 (-0.21, 0.22)quintile 349-0.11 (-0.35, 0.14)-0.18 (-0.41, 0.06)quintile 4510.02 (-0.22, 0.26)0.04 (-0.20, 0.28)quintile 558-0.06 (-0.30, 0.17)0.08 (-0.17, 0.33)p for linear trendp = 0.459\n&number of children colonized;\n#adjusted for: place and mode of Delivery, number of siblings, recruitment group, total bacterial counts, sex, vaginitis during the last month of Pregnancy, mode of infant nutrition and season of Blood sampling; quintile 5 is the highest quintile;\n* remained statistically significant after correction with fdr (q < 0.05)\n\nVitamin D supplementation of the infant\nthere was no influence of Vitamin D supplementation of the infant during the first month of Life on the prevalence of any of the bacterial species or groups (data not shown).table 5shows the ASSOCIATION between Vitamin D supplementation of the infant in the first month of Life and the log10cfus of the different bacteria in children colonized with the respective bacterial group or species (for a visualisation of the data in univariable boxplots see alsos3 fig).10.1371/journal.pone.0188011.t005\n\ncaption (table-wrap): table 5\nassociation between Vitamin D supplementation of the infant and log10colony forming units/g Feces of bacterial species or groups in Breast Fed infants (n = 616) colonized with the respective bacteria.Vitamin D supplement use of Breast feeding infantsvitamin D supplementationbacteria&nunadjusted b (95% ci)#adjusted b (95% ci)no use bifidobacterium spp.']	[('SUPERFICIAL_RELATIONSHIP', 836)]	1	[('GO_0007567', 'parturition', 315, 'delivery'), ('GO_0007565', 'female pregnancy', 428, 'pregnancy'), ('UBERON_0000178', 'blood', 478, 'blood'), ('CHEBI_28384', 'vitamin K', 605, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 671, 'vitamin D'), ('UBERON_0000104', 'life cycle', 737, 'life'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('UBERON_0000104', 'life cycle', 918, 'life'), ('CHEBI_27300', 'vitamin D', 1194, 'vitamin D'), ('UBERON_0001988', 'feces', 1266, 'feces'), ('GO_0007567', 'parturition', 1306, 'breast'), ('UBERON_0000310', 'breast', 1306, 'breast'), ('GO_0007631', 'feeding behavior', 1313, 'fed'), ('CHEBI_28384', 'vitamin K', 1374, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1374, 'Vitamin'), ('UBERON_0000310', 'breast', 1402, 'Breast'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1432, 'D')]
S10-PMC5716389	PMC5716389	9/2017	S10-PMC5716389	['maternal nutritional status, and exposure during fetal Life to an inadequately nurturing environment, COULD THUS IMPACT fetal Immune Development [3,4], in particular, Micronutrients including zinc, iron, Vitamin A and protein energy malnutrition (pem).']	[('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('UBERON_0000104', 'life cycle', 55, 'life'), ('GO_0001822', 'kidney development', 126, 'immune development'), ('UBERON_0002405', 'immune system', 126, 'immune'), ('CHEBI_33839', 'macromolecule', 167, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A')]
S0-PMC5758521	PMC5758521	1/2018	S0-PMC5758521	['vitamin a and e nutritional status in RELATION to leptin, adiponectin, Igf-I and Igf-Ii in early Life - a Birth cohort study\n\nabstract\nthe Metabolic health EFFECTS of Vitamin A and E nutritional status in early Life are largely UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 156), ('FULL_UNKNOWN', 228)]	3	[('PR_000008919', 'interferon alpha-6', 71, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 81, 'IGF-II'), ('UBERON_0000104', 'life cycle', 97, 'Life'), ('GO_0007567', 'parturition', 106, 'Birth'), ('GO_0008152', 'metabolic process', 139, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 181, 'E'), ('UBERON_0000104', 'life cycle', 211, 'life')]
S1-PMC5758521	PMC5758521	1/2018	S1-PMC5758521	['we ASSESSED WHETHER Vitamin A and Vitamin E nutritional status MAY AFFECT circulating leptin, adiponectin, Insulin-Like Growth Factor (Igf)-I and Igf-Ii levels in early Life in Humans.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('PR_000008929', 'interferon-related developmental regulator 1', 107, 'insulin-like growth factor ...'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 135, 'IGF)-I'), ('PR_000002046', 'interferon regulatory factor 4', 146, 'IGF-II'), ('UBERON_0000104', 'life cycle', 169, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 177, 'humans')]
S9-PMC5758521	PMC5758521	1/2018	S9-PMC5758521	['however, the Metabolic health EFFECTS of Vitamin A and E nutritional status in early Life remain largely UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('FULL_UNKNOWN', 105)]	2	[('GO_0008152', 'metabolic process', 13, 'metabolic'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 55, 'E'), ('UBERON_0000104', 'life cycle', 85, 'life')]
S20-PMC5758521	PMC5758521	1/2018	S20-PMC5758521	['HOWEVER, there is a LACK OF DATA on WHETHER Vitamin A and E nutritional status MAY BE ASSOCIATED with Metabolic health BIOMARKERS in early Life in Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 119)]	7	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0008152', 'metabolic process', 102, 'metabolic'), ('UBERON_0000104', 'life cycle', 139, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 147, 'humans')]
S119-PMC5758521	PMC5758521	1/2018	S119-PMC5758521	['these observations SUGGEST that Vitamin E and a nutritional status MAY matter for Metabolic health in early Life in Humans.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 67)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin E'), ('GO_0008152', 'metabolic process', 82, 'metabolic'), ('UBERON_0000104', 'life cycle', 108, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 116, 'humans')]
S128-PMC5758521	PMC5758521	1/2018	S128-PMC5758521	['THUS, our OBSERVED negative ASSOCIATIONS of Cord Blood Vitamin E with leptin and adiponectin SUGGEST a POTENTIAL beneficial ROLE of Vitamin E in early Life in preventing the development of childhood obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('UBERON_0009472', 'axilla', 44, 'cord blood'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin E'), ('UBERON_0000104', 'life cycle', 151, 'life')]
S0-PMC5784894	PMC5784894	1/2018	S0-PMC5784894	['early Life Vitamin D depletion alters the Postnatal response to Skeletal loading in Growing and mature bone\n\nabstract\nthere is INCREASING EVIDENCE of persistent EFFECTS of early Life Vitamin D exposure on later Skeletal health; LINKING low levels in early Life to smaller bone size in childhood as well as increased fracture risk later in Adulthood, INDEPENDENTLY of later Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 350)]	4	[('UBERON_0000104', 'life cycle', 6, 'life'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007567', 'parturition', 42, 'postnatal'), ('UBERON_0004288', 'skeleton', 64, 'skeletal'), ('GO_0040007', 'growth', 84, 'growing'), ('UBERON_0000104', 'life cycle', 178, 'life'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0004288', 'skeleton', 211, 'skeletal'), ('UBERON_0000104', 'life cycle', 256, 'life'), ('UBERON_0000113', 'post-juvenile adult stage', 339, 'adulthood'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D')]
S6-PMC5784894	PMC5784894	1/2018	S6-PMC5784894	['early Life Vitamin D depletion LED TO reduced bone strength and altered bone biomechanical properties.']	[('SUPERFICIAL_RELATIONSHIP', 31)]	1	[('UBERON_0000104', 'life cycle', 6, 'life'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
S7-PMC5784894	PMC5784894	1/2018	S7-PMC5784894	['THESE FINDINGS SUGGEST early Life Vitamin D status MAY, IN PART, determine the propensity to osteoporosis and fracture that blights later Life in many Individuals.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 56)]	4	[('UBERON_0000104', 'life cycle', 29, 'life'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0000104', 'life cycle', 138, 'life'), ('NCBITaxon_1', 'root', 151, 'individuals')]
S20-PMC5784894	PMC5784894	1/2018	S20-PMC5784894	['[14]\nconsidered TOGETHER, THESE FINDINGS IMPLY that early Life Vitamin D exposure has EFFECTS that persist into childhood, MAY IMPACT on peak bone mass accrual and INFLUENCE subsequent bone loss, the development of osteoporosis and the risk of Life-limiting fracture.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000104', 'life cycle', 244, 'life')]
S136-PMC5784894	PMC5784894	1/2018	S136-PMC5784894	['discussion\nTHIS STUDY REPLICATES the real Life situation of early Life Vitamin D deficiency in the infant who is Born to a Vitamin D deficient mother and then exclusively breast Fed until weaning.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 22)]	2	[('UBERON_0000104', 'life cycle', 42, 'life'), ('UBERON_0000104', 'life cycle', 66, 'life'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007567', 'parturition', 113, 'born'), ('CHEBI_28384', 'vitamin K', 123, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 178, 'fed')]
S137-PMC5784894	PMC5784894	1/2018	S137-PMC5784894	['in THIS STUDY we HAVE SHOWN that early Life Vitamin D deficiency LEADS to decreased bone strength and negatively IMPACTS structure in the bone of Growing and mature female Mice.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('UBERON_0000104', 'life cycle', 39, 'life'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0040007', 'growth', 146, 'growing'), ('NCBITaxon_10088', 'Mus <genus>', 172, 'mice')]
S138-PMC5784894	PMC5784894	1/2018	S138-PMC5784894	['IMPORTANTLY, and for the FIRST TIME, we have DEMONSTRATED that for those with early Life Vitamin D deficiency, the Anabolic response of bone to mechanical loading is reduced in Growing bone, AFFECTING both Cortical and Trabecular Bone, with the EFFECT on Cortical bone persisting into “Adult” Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 191), ('SUPERFICIAL_RELATIONSHIP', 245)]	5	[('UBERON_0000104', 'life cycle', 84, 'life'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 115, 'anabolic'), ('GO_0040007', 'growth', 177, 'growing'), ('UBERON_0001851', 'cortex', 206, 'cortical'), ('UBERON_0002483', 'trabecular bone tissue', 219, 'trabecular bone'), ('UBERON_0001851', 'cortex', 255, 'cortical'), ('UBERON_0007023', 'adult organism', 286, 'adult'), ('UBERON_0000104', 'life cycle', 293, 'life')]
S144-PMC5784894	PMC5784894	1/2018	S144-PMC5784894	['that these changes are present in Mice that, following weaning, are Vitamin D replete throughout Life INDICATES that early Life, AS OPPOSED TO current, Vitamin D status is the cause of these differences.']	[('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129)]	2	[('NCBITaxon_10088', 'Mus <genus>', 34, 'mice'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('UBERON_0000104', 'life cycle', 123, 'life'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
S148-PMC5784894	PMC5784894	1/2018	S148-PMC5784894	['THESE FINDINGS are CONSISTENT with multiple data sources that LINK early Life Vitamin D status to later bone size[4,8,9,25], structure[6,26], mass[8,9,26,27] and risk of fracture[9].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('UBERON_0000104', 'life cycle', 73, 'life'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
S189-PMC5784894	PMC5784894	1/2018	S189-PMC5784894	['identification of specific pathways is being pursued with a VIEW to BETTER UNDERSTANDING the CONTRIBUTION of early Life Vitamin D to bone health in later Life and to identify new pathways that COULD IMPACT on osteoporosis PREVENTION and treatment.']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 222)]	6	[('UBERON_0000104', 'life cycle', 115, 'life'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('UBERON_0000104', 'life cycle', 154, 'life')]
S95-PMC5941617	PMC5941617	5/2018	S95-PMC5941617	['CONSIDERING Water REQUIREMENTS, formula Fed infants MAY receive 400\xa0iu/day of Vitamin D, which is adequate for the first year of Life [10], only when they come to weigh 5 to 6 kg.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 52)]	4	[('CHEBI_15377', 'water', 12, 'water'), ('GO_0007631', 'feeding behavior', 40, 'fed'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000104', 'life cycle', 129, 'life')]
S104-PMC5941617	PMC5941617	5/2018	S104-PMC5941617	['assuming minimal sunshine exposure, sacn RECOMMENDED a SAFE intake of 340–400\xa0iu/day of Vitamin D for infants under 1\xa0year of Life, a SAFE intake of 400\xa0iu/day for age 1 up to 4\xa0years, and a reference Nutrient intake of 400\xa0iu/day for the united kingdom population aged 4\xa0years and above [25].']	[('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 134)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0000104', 'life cycle', 126, 'life'), ('CHEBI_33284', 'nutrient', 201, 'nutrient')]
S106-PMC5941617	PMC5941617	5/2018	S106-PMC5941617	['WHILE there is sufficient global agreement in considering 400\xa0iu/day as dietary reference value for Vitamin D during the first year of Life, RECOMMENDED reference values for children and adolescents (1–18\xa0years) slightly differ between organizations and societies, reflecting DIFFERENT approaches and methods applied to calculate them.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 276)]	3	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0000104', 'life cycle', 135, 'life')]
S108-PMC5941617	PMC5941617	5/2018	S108-PMC5941617	['particularly, the Endocrine society guidelines focused on patients AT RISK for Vitamin D deficiency, RECOMMENDING a Vitamin D daily REQUIREMENT of 400–1000\xa0iu in the first years of Life and of 600–1000\xa0iu from 1 up to 18\xa0years [11].']	[('IMPORTANT_CONSIDERATION', 67), ('FUTURE_WORK', 101), ('IMPORTANT_CONSIDERATION', 132)]	3	[('UBERON_0005063', 'left ventricular compact myocardium', 18, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0000104', 'life cycle', 181, 'life')]
S110-PMC5941617	PMC5941617	5/2018	S110-PMC5941617	['Vitamin D supplementation\n\n0–12\xa0months\nvitamin D supplementation in the first year of Life is ESSENTIAL to ensure an adequate Vitamin D status and to prevent nutritional rickets.']	[('IMPORTANT_CONSIDERATION', 94)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 47, 'D'), ('UBERON_0000104', 'life cycle', 86, 'life'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
S114-PMC5941617	PMC5941617	5/2018	S114-PMC5941617	['the IMPORTANCE of Vitamin D supplementation during the first year of Life HAS BEEN CONFIRMED by the FINDING that children not receiving supplementation have reduced Serum 25(Oh)d levels, PARTICULARLY if exclusively Breastfed and during winter season [94–96].']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 100), ('ANOMALY_CURIOUS_FINDING', 187)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('GO_0007567', 'parturition', 215, 'breastfed')]
S115-PMC5941617	PMC5941617	5/2018	S115-PMC5941617	['SOME STUDIES evaluated the EFFECT of daily Vitamin D supplementation at variable dosages (ranging from 200 to 1600\xa0iu/day) on Vitamin D status in children during the first year of Life [52,62,97–107].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
S119-PMC5941617	PMC5941617	5/2018	S119-PMC5941617	['ONLY FEW STUDIES evaluated the EFFICACY and SAFETY of intermittent Vitamin D supplementation during the first year of Life, particularly in cases with low compliance [109–111], THUS AT PRESENT daily supplementation REMAINS PREFERRED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 44), ('PROBABLE_UNDERSTANDING', 177), ('INCOMPLETE_EVIDENCE', 182), ('INCOMPLETE_EVIDENCE', 215), ('PROBABLE_UNDERSTANDING', 223)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
S120-PMC5941617	PMC5941617	5/2018	S120-PMC5941617	['various international scientific societies agree to RECOMMEND Vitamin D supplementation during the first year of Life [9,12–15,19,20,22,23,27,28,30,112–116].']	[('FUTURE_WORK', 52)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000104', 'life cycle', 113, 'life')]
S126-PMC5941617	PMC5941617	5/2018	S126-PMC5941617	['DESPITE this GLOBAL agreement on Vitamin D supplementation in the first year of Life, several barriers to adherence STILL exist, such as reluctance of mothers to give their children daily supplementation, lack OF knowledge about Vitamin D actions and the RISK of nutritional rickets, lack of awareness by health care professionals, ASSUMPTION that both breast milk and formula milk provide sufficient Vitamin D intake [116,117].']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 116), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 255), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 332)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0000104', 'life cycle', 80, 'life'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 401, 'vitamin D')]
S127-PMC5941617	PMC5941617	5/2018	S127-PMC5941617	['in the present consensus we RECOMMEND Vitamin D supplementation in all newborns independently of the type of Feeding, starting from Birth and continuing throughout the first year of Life.']	[('FUTURE_WORK', 28)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007631', 'feeding behavior', 109, 'feeding'), ('GO_0007567', 'parturition', 132, 'birth'), ('UBERON_0000104', 'life cycle', 182, 'life')]
S139-PMC5941617	PMC5941617	5/2018	S139-PMC5941617	['in addition to optimize bone mineralization during fetal Life, Vitamin D status HAS BEEN ASSOCIATED with acute Respiratory morbidity in preterm infants Born <\u200932\xa0weeks Gestation [124].']	[('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('UBERON_0000104', 'life cycle', 57, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 111, 'respiratory'), ('GO_0007567', 'parturition', 152, 'born'), ('GO_0007565', 'female pregnancy', 168, 'gestation')]
S143-PMC5941617	PMC5941617	5/2018	S143-PMC5941617	['DIFFERENTLY, CONSIDERING the high prevalence of Vitamin D deficiency during Pregnancy, the espghan RECOMMENDED for preterm infants a Vitamin D intake of 800–1000\xa0iu/day during the first months of Life to rapidly correct fetal low Serum 25(Oh)D levels [125].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('FUTURE_WORK', 99)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 230, 'serum'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 236, '25(OH ... D')]
S191-PMC5941617	PMC5941617	5/2018	S191-PMC5941617	['as REPORTED for infants in the first years of Life, we RECOMMEND against using Vitamin D Metabolites and their analogs (Calcifediol, Alfacalcidol, Calcitriol, and Dihydrotachysterol) for the routine Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 55)]	2	[('UBERON_0000104', 'life cycle', 46, 'life'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_25212', 'metabolite', 89, 'metabolites'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 120, 'calcifediol'), ('CHEBI_31186', 'alfacalcidol', 133, 'alfacalcidol'), ('CHEBI_17823', 'calcitriol', 147, 'calcitriol'), ('CHEBI_4657', 'disopyramide', 163, 'dihydrotachysterol'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D')]
S233-PMC5941617	PMC5941617	5/2018	S233-PMC5941617	['after rickets healing, Vitamin D supplementation SHOULD continue according to age (AT LEAST 400\xa0iu/day in the first year of Life and 600\xa0iu/day from 1 to 18\xa0years) [11,23,28,183,188].']	[('FUTURE_WORK', 49), ('PROBABLE_UNDERSTANDING', 83)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life')]
S249-PMC5941617	PMC5941617	5/2018	S249-PMC5941617	['as discussed before, Vitamin D supplementation during the first year of Life is ESSENTIAL to prevent nutritional rickets occurrence.']	[('IMPORTANT_CONSIDERATION', 80)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life')]
S250-PMC5941617	PMC5941617	5/2018	S250-PMC5941617	['a FEW STUDIES evaluated the RELATIONSHIP between Vitamin D status and bone mass during this period of Life [52,62,97,104,201–203].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 102, 'life')]
S253-PMC5941617	PMC5941617	5/2018	S253-PMC5941617	['moreover, studies comparing supplementation with placebo or different regimens of Vitamin D supplementation (up to 1600\xa0iu/day) did not FIND any difference in infant bone mass at 3\xa0months [104], 6\xa0months [97], 1\xa0year [62] or 3\xa0years of Life [204].']	[('INCOMPLETE_EVIDENCE', 136)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0000104', 'life cycle', 236, 'life')]
S283-PMC5941617	PMC5941617	5/2018	S283-PMC5941617	['HOWEVER, the most RECENT STUDY SUGGESTED that Vitamin D status during childhood MIGHT be more RELEVANT for bone health that maternal 25(Oh)D levels during fetal Life [237].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('UBERON_0000104', 'life cycle', 161, 'life')]
S294-PMC5941617	PMC5941617	5/2018	S294-PMC5941617	['also DEMONSTRATED that Cord Blood Vitamin D levels <\u200920\xa0ng/ml were ASSOCIATED with a sixfold (95% ci: 1.6–24.9) increased risk of Respiratory syncytial Virus lower Respiratory Tract infections in the first year of Life as compared with concentrations ≥30\xa0ng/ml [249].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('UBERON_0002240', 'spinal cord', 23, 'cord'), ('UBERON_0000178', 'blood', 28, 'blood'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('NCBITaxon_1', 'root', 152, 'virus'), ('UBERON_0000065', 'respiratory tract', 164, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 214, 'life')]
S357-PMC5941617	PMC5941617	5/2018	S357-PMC5941617	['SEVERAL STUDIES SHOWED that Vitamin D deficiency in utero and in early Life was ASSOCIATED with an increase in Th2 Lymphocyte Cells and a reduction in T Regulatory Cells and Production Of Interleukin (Il)-10, which subsequently MAY activate pro-inflammatory Cytokine Production through Macrophages and Dendritic Cells [306–308].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 228)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('CL_0000546', 'T-helper 2 cell', 111, 'Th2 lymphocyte cells'), ('CL_0000902', 'induced T-regulatory cell', 151, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 153, 'regulatory'), ('GO_0030154', 'cell differentiation', 174, 'production of interleukin ... IL ... 10'), ('PR_000001470', 'interleukin-28B', 188, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 201, 'IL)-10'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 258, 'cytokine production'), ('CL_0000235', 'macrophage', 286, 'macrophages'), ('CL_0000451', 'dendritic cell', 302, 'dendritic cells')]
S366-PMC5941617	PMC5941617	5/2018	S366-PMC5941617	['OBSERVATIONAL studies on the RELATIONSHIP between Vitamin D in Pregnancy and wheezing, asthma, and allergies Development in early Life SHOWED UNCLEAR results.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 135), ('FULL_UNKNOWN', 142)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('GO_0048513', 'animal organ development', 109, '... development'), ('UBERON_0000104', 'life cycle', 130, 'life')]
S420-PMC5941617	PMC5941617	5/2018	S420-PMC5941617	['a meta-analysis of six case-control studies and two cohort-studies SHOWED a reduction of the RISK of t1dm in later Life (odds ratio: 0.71; 95% ci 0.51–0.98) in infants who were supplemented with Vitamin D compared with controls, ALTHOUGH the needed time of supplementation and the dose are STILL UNCLEAR [377–379].']	[('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 93), ('ANOMALY_CURIOUS_FINDING', 229), ('FULL_UNKNOWN', 290)]	4	[('UBERON_0000104', 'life cycle', 115, 'life'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
S422-PMC5941617	PMC5941617	5/2018	S422-PMC5941617	['IF data of OBSERVATIONAL studies in general population in infancy are ENCOURAGING, in the daisy study, conducted in subjects at higher RISK, the Vitamin D nutritional intake in the first years of Life as well as the Serum 25(Oh)D levels at 9\xa0months of age were not associated with the development of Autoantibodies or with the progression to t1dm [381].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('FUTURE_WORK', 70), ('IMPORTANT_CONSIDERATION', 135)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 216, 'serum'), ('CHEBI_71657', 'versiconol acetate', 222, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 222, '25 ... OH ... D'), ('GO_0044308', 'axonal spine', 300, 'autoantibodies')]
S459-PMC5941617	PMC5941617	5/2018	S459-PMC5941617	['it HAS BEEN SUGGESTED that early-Life Vitamin D deficiency MAY CONTRIBUTE to the pathogenesis of childhood-onset cd by determining inappropriate Immune Responses, abnormal Intestinal Mucosal integrity and impaired local Defence against Microbial agents [413].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0000104', 'life cycle', 33, 'life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0006955', 'immune response', 145, 'immune responses'), ('UBERON_0002405', 'immune system', 145, 'immune'), ('UBERON_0001262', 'wall of intestine', 172, 'intestinal mucosal'), ('GO_0006952', 'defense response', 220, 'defence'), ('NCBITaxon_10088', 'Mus <genus>', 236, 'microbial')]
S611-PMC5941617	PMC5941617	5/2018	S611-PMC5941617	['particularly, Vitamin D supplementation SHOULD BE RECOMMENDED in all infants in the first year of Life, independently of the type of Feeding.']	[('FUTURE_WORK', 40), ('FUTURE_WORK', 50)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000104', 'life cycle', 98, 'life'), ('GO_0007631', 'feeding behavior', 133, 'feeding')]
S621-PMC5941617	PMC5941617	5/2018	S621-PMC5941617	['Vitamin D supplementation\n\n0–12\xa0months\n\nwe RECOMMEND Vitamin D supplementation in the first year of Life to ensure an adequate Vitamin D status and to prevent nutritional rickets.']	[('FUTURE_WORK', 43)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
S625-PMC5941617	PMC5941617	5/2018	S625-PMC5941617	['in the first year of Life we RECOMMEND daily administration of Vitamin D.\nwe RECOMMEND against using Vitamin D Metabolites and their analogs (Calcifediol, Alfacalcidol, Calcitriol, and Dihydrotachysterol) for the routine Vitamin D supplementation.']	[('FUTURE_WORK', 29), ('FUTURE_WORK', 77)]	2	[('UBERON_0000104', 'life cycle', 21, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_25212', 'metabolite', 111, 'metabolites'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 142, 'calcifediol'), ('CHEBI_31186', 'alfacalcidol', 155, 'alfacalcidol'), ('CHEBI_17823', 'calcitriol', 169, 'calcitriol'), ('CHEBI_4657', 'disopyramide', 185, 'dihydrotachysterol'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
S658-PMC5941617	PMC5941617	5/2018	S658-PMC5941617	['after rickets healing, we RECOMMEND to continue Vitamin D supplementation according to age (400–1000\xa0iu/day in the first year of Life and 600–1000\xa0iu/day from 1 to 18\xa0years).']	[('FUTURE_WORK', 26)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0000104', 'life cycle', 129, 'life')]
S16-PMC5952272	PMC5952272	5/2018	S16-PMC5952272	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
S112-PMC5952272	PMC5952272	5/2018	S112-PMC5952272	['while all Nutrients are IMPORTANT for Brain Development, certain Nutrients (eg, protein, Long-Chain polyunsaturated Fatty Acids, iron, copper, zinc, Iodine, Folate, Choline, and Vitamins A, B6, and B12) have particularly large EFFECTS early in Life and exhibit CRITICAL or sensitive periods for Neurodevelopment.8all highly Metabolic, rapidly developing Organs have high iron requirements BECAUSE iron supports fundamental Metabolic Processes.9early-Life id is PARTICULARLY DETRIMENTAL as this is a period of rapid Neurodevelopment.']	[('IMPORTANT_CONSIDERATION', 24), ('SUPERFICIAL_RELATIONSHIP', 227), ('IMPORTANT_CONSIDERATION', 261), ('PROBABLE_UNDERSTANDING', 389), ('ANOMALY_CURIOUS_FINDING', 461), ('IMPORTANT_CONSIDERATION', 474)]	6	[('CHEBI_33284', 'nutrient', 10, 'nutrients'), ('GO_0007420', 'brain development', 38, 'brain development'), ('UBERON_0000955', 'brain', 38, 'brain'), ('CHEBI_33284', 'nutrient', 65, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 89, 'long-chain'), ('CHEBI_35366', 'fatty acid', 116, 'fatty acids'), ('CHEBI_24859', 'iodine atom', 149, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 157, 'folate'), ('CHEBI_15354', 'choline', 165, 'choline'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 178, 'vitamins A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 190, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 198, 'B12'), ('UBERON_0000104', 'life cycle', 244, 'life'), ('GO_0007399', 'nervous system development', 295, 'neurodevelopment'), ('GO_0008152', 'metabolic process', 324, 'metabolic'), ('UBERON_0000062', 'organ', 354, 'organs'), ('GO_0008152', 'metabolic process', 423, 'metabolic processes'), ('UBERON_0000104', 'life cycle', 450, 'life'), ('GO_0007399', 'nervous system development', 515, 'neurodevelopment')]
S141-PMC5952272	PMC5952272	5/2018	S141-PMC5952272	['methionine MAY then be activated by methionine adenosyltransferase to form S-Adenosylmethionine (sam), the primary Methyl Donor for most cellular methyltransferase reactions, including the methylation of dna, rna, proteins, Phospholipids, and Neurotransmitters.34\n\nVitamin D status as a risk factor for autism\nthe main source of Vitamin D is the solar uv-b radiation–RELATED Conversion Of 7-Dehydrocholesterol to Previtamin D3 in the skin and a lesser amount of Vitamin D from Food.35there is a GROWING BODY of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a risk of autism.36moreover, epidemiologic EVIDENCE SUPPORTS the ROLE of maternal Vitamin D deficiency AS a RISK FACTOR for the development of infantile autism.37maternal status of Vitamin D IS CONSIDERED INSUFFICIENT not ONLY in countries where solar radiation is low but also in very sunny places such saudi arabia, uae, iran, and jordan.38\nVitamin D functions in the body have been extensively studied by researchers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 367), ('INCOMPLETE_EVIDENCE', 495), ('INCOMPLETE_EVIDENCE', 525), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 572), ('INCOMPLETE_EVIDENCE', 589), ('INCOMPLETE_EVIDENCE', 639), ('INCOMPLETE_EVIDENCE', 648), ('SUPERFICIAL_RELATIONSHIP', 661), ('PROBABLE_UNDERSTANDING', 699), ('SUPERFICIAL_RELATIONSHIP', 704), ('INCOMPLETE_EVIDENCE', 787), ('PROBLEM_COMPLICATION', 801), ('INCOMPLETE_EVIDENCE', 818)]	15	[('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 75, 'S-adenosylmethionine'), ('CHEBI_81933', 'methasulfocarb', 115, 'methyl donor'), ('CHEBI_16247', 'phospholipid', 224, 'phospholipids'), ('CHEBI_25512', 'neurotransmitter', 243, 'neurotransmitters'), ('CHEBI_28384', 'vitamin K', 265, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('GO_0048669', 'collateral sprouting in absence of injury', 375, 'conversion of ... dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 389, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 413, 'previtamin D3'), ('CHEBI_29238', 'tritium atom', 424, 'D3'), ('CHEBI_27300', 'vitamin D', 462, 'vitamin D'), ('CHEBI_33290', 'food', 477, 'food'), ('CHEBI_27300', 'vitamin D', 539, 'vitamin D'), ('UBERON_0000104', 'life cycle', 584, 'life'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 777, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 939, 'Vitamin D')]
S239-PMC5956785	PMC5956785	5/2018	S239-PMC5956785	['exploring elements of Vitamin D status that MAY have a ROLE in disease development such as early Life and Gestational Vitamin D status as well as Genes in the Vitamin D pathway will help TO CLARIFY the ROLE of Vitamin D.\nseason of Birth HAS BEEN SUGGESTED to have an IMPACT on the risk of developing a number of Autoimmune diseases such as multiple sclerosis, type 1 diabetes and celiac disease [78].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 55), ('FUTURE_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 231, 'birth'), ('UBERON_0001442', 'skeleton of manus', 312, 'autoimmune')]
S284-PMC5956785	PMC5956785	5/2018	S284-PMC5956785	['being able to SUGGEST specific TARGETS for Vitamin D status AS a POTENTIAL adjunct therapy in the treatment of jia and understanding HOW Genetic variants increase the RISK of disease development will enhance the quality of Life of patients and their families.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 31), ('PROBABLE_UNDERSTANDING', 60), ('INCOMPLETE_EVIDENCE', 65), ('EXPLICIT_QUESTION', 133), ('IMPORTANT_CONSIDERATION', 167)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('SO_0000704', 'gene', 137, 'genetic'), ('UBERON_0000104', 'life cycle', 223, 'life')]
S34-PMC5995352	PMC5995352	6/2018	S34-PMC5995352	['ALTHOUGH maternal Vitamin D status during Pregnancy has no impact on foetal Bone mineralisation IF Calcium supply is adequate, observational studies have LINKED low maternal Vitamin D levels with smaller child bone mass and impaired linear growth in the first 12 months of Life [18–20].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('SUPERFICIAL_RELATIONSHIP', 154)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007567', 'parturition', 76, 'bone'), ('CHEBI_22313', 'alkaline earth metal atom', 99, 'calcium'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('UBERON_0000104', 'life cycle', 273, 'life')]
S39-PMC5995352	PMC5995352	6/2018	S39-PMC5995352	['on this background we AIMED TO INVESTIGATE the RELATIONSHIP between early Life Vitamin D exposure and linear growth in children up to three years of age in the large, danish, population-based odense child cohort (occ).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('UBERON_0000104', 'life cycle', 74, 'life'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
S187-PMC5995352	PMC5995352	6/2018	S187-PMC5995352	['in conclusion, early Life Vitamin D status had no clinically IMPORTANT associations with linear growth in a generally healthy population of infants.']	[('IMPORTANT_CONSIDERATION', 61)]	1	[('UBERON_0000104', 'life cycle', 21, 'life'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
